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ABSTRACT
THE MANIPULATION OF HOST TRANSCRIPTION BY THE ANKH EFFECTOR
OF LEGIONELLA
Juanita Von Dwingelo
August 15, 2019
Legionella pneumophila is a Gram-negative facultative intracellular bacterium that can be
found dispersed throughout freshwater environments, where it primarily parasitizes
amoebae and other protozoan species. Humans are an accidental host for L. pneumophila,
and infection occurs upon inhalation of aerosolized water droplets that contain the
bacteria. L. pneumophila is the causative agent of Legionnaires’ Disease, which is the
result of intracellular proliferation within alveolar macrophages. Pathogenesis of L.
pneumophila is dependent on the Dot/Icm type 4 secretion system (T4SS) apparatus,
which is comprised of 27 proteins and is responsible for translocating over 330 effector
proteins into the host cell. Many of these effector proteins contain eukaryotic-like
domains and motifs, which have been acquired through interkingdom horizontal gene
transfer from various aquatic eukaryotic hosts. While L. pneumophila contains such a
large repertoire of effector proteins, most of them are not required for survival and
proliferation in mammalian macrophages, since single deletion of most effectors does not
result in a defect in intracellular replication. Although this could be explained by effector
redundancy, it is more likely that these effector proteins constitute a tool box utilized by
L. pneumophila to survive and replicate within numerous species of protozoa. One
v

effector identified, that when deleted results in a defect in intracellular replication, is the
AnkH effector. It has been shown that AnkH is required for robust intracellular
replication of L. pneumophila within amoebae, human macrophages and the A/J mouse
model of infection. It has previously been shown that AnkH is an effector that contains
ankyrin repeats, which are eukaryotic-like domains, and function as a scaffold for
protein-protein interactions. Other than requirement of AnkH during intracellular
replication, its function and host targets remain unknown and are the focus of this work.
We further characterized AnkH to elucidate its host target and function during infection
of macrophages. Using a yeast 2 hybrid system, seven potential host interacting partners
have been identified and one interacting partner, human La related protein 7 (LARP7),
has been confirmed via co-immunoprecipitation. LARP7 is a component of a
transcriptional regulatory complex, 7SK snRNP complex that negatively regulates
transcriptional elongation. The AnkH -LARP7 interaction blocks LARP7 binding to
components of the 7SK snRNP complex, resulting in the disruption of the complex.
Knockdown of LARP7 using LARP7 specific RNAi results in a significant growth defect
of the WT strain during infection of macrophages, and the growth defect of the ∆ankH
null mutant becomes more severe. RNAseq has been performed on macrophages infected
with either WT or ∆ankH strains of L. pneumophila to determine modulation of
transcription during infection. The data show that there are a total of 405 genes that are
differentially regulated in cells infected with WT versus the ∆ankH mutant. The crystal
structure of AnkH has been resolved, and it revealed that AnkH contains 4 ankyrin
repeats, 2 asparagine hydroxylation motifs, a cysteine-like protease domain and a cap
domain. When residues are substituted within the ankyrin repeats, asparagine
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hydroxylation sites and cysteine-like protease domain, a decrease in intracellular
replication is observed, indicating these domains are critical for the function of AnkH. A
substitution within the β-hairpin loop of the third ankyrin repeat results in diminished
LARP7-AnkH interactions, and phenocopies the ΔankH null mutant defect in
intracellular growth. Taken together, these data suggest that the β-hairpin loop of the
third ankyrin repeat of AnkH interacts with the host LARP7, which disrupts host cell
transcription elongation by inhibiting assembly of the 7SK snRNP complex resulting in
global modulation of transcription. This interaction is important for the intracellular
replication of L. pneumophila in human macrophages. The ARDs, asparagine
hydroxylation motifs and cysteine-like protease pocket are all required for the function of
AnkH in intracellular replication of WT L. pneumophila. AnkH is an important effector
protein that aids in the survival and replication of L. pneumophila in all hosts, the study
of which would result in a better understanding of how L. pneumophila creates an
environment within host cells that supports robust intracellular replication.
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INTRODUCTION
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INTRODUCTION
Discovery of Legionnaires’ Disease
In July of 1976, Philadelphia, PA was host to the bicentennial celebration of the
formation of the United States as well as the 56th annual American Legion Convention.
The 4-day gathering was attended by more than 2,000 American Legion delegates and
was hosted at the Bellevue-Stratford Hotel. After the convention, numerous attendees
suffered from pneumonia-like symptoms. In total, 182 of the convention attendees
reported symptoms and a total of 34 individuals succumbed to the mysterious disease,
nicknamed the “Philly Killer” [1].
At first, it was feared that this disease was caused by a new strain of Influenza.
The outbreak prompted a high-profile investigation by the Centers for Disease Control
and Prevention (CDC). It was determined early in the investigation that the outbreak was
caused by a previously unidentified agent. The investigation lasted close to six months
and was worked on by multiple teams of parasitologists, virologists, epidemiologists,
bacteriologists, and toxicologists. In January 1977, the causative agent was identified but
was called the Legionnaires’ Disease bacterium until April 1979. The bacteria was given
a name representing the disease caused as well as those who were affected by the first
documented outbreak, Legionella pneumophila [1-3].
What was unknown when the investigation began was the unique nutritional
requirements of L. pneumophila that makes it difficult to culture and isolate. Unless a
special kind of agar plates are used. Moreover, the bacteria replicate within alveolar
macrophages making identification from lung tissue secretion difficult. The use of guinea
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pigs by the CDC led to the identification of L. pneumophila since guinea pigs are
susceptible to infection with Legionella [2].
The Legionella genus consists of approximately 65 species with half (30 species)
known to cause disease [4]. L. pneumophila remains the primary causative agent of
Legionnaires’ disease globally, causing 95% of reported cases. However, in Australia L.
longbeachae causes most reported cases of disease [5, 6]. L. pneumophila can be
subdivided into 16 serogroups with most of confirmed cases caused by serogroup 1 (Lp1)
[4, 7, 8].

Legionnaires’ Disease
Infection with L. pneumophila results in two distinct clinical manifestations –
Pontiac Fever or Legionnaires’ Disease [4, 9]. Pontiac Fever is a mild, self-limiting flu
like illness which usually resolves in 2 to 5 days and does not benefit from any treatment
with antibiotics. Legionnaires’ disease can be a multisystem disease and is the pneumonic
form of legionellosis that has a case fatality rate of 10%. In immunocompromised and
immunosuppressed patients mortality is increased as much as 25% [9]. Immune
compromised individuals and smokers are more susceptible to Legionnaires’ disease but
healthy individuals are also at risk for contracting the disease [10, 11]. The incubation
period for both forms of disease varies with symptoms surfacing anywhere from 2-14
days after inoculation. The symptoms of Legionnaires’ disease include cough, fever,
headache, shortness of breath and muscle pains. Patients with a more severe form of the
disease may show symptoms including diarrhea, bloody sputum, ataxia, vomiting, and/or
loss of appetite [12]. Death is usually the result of multi organ failure or respiratory shock
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[13]. No vaccines exist to protect from Legionnaires’ Disease but the disease can be
successfully treated with antibiotics including macrolides, tetracyclines, and quinolones,
which to date are the most effective [14-16]. Legionnaires’ disease cannot be successfully
treated with penicillin and β-lactams as a result of the resistance of L. pneumophila to the
antibiotics. Treatment with these antibiotics also leads to an increased mortality.
Legionnaires’ disease is likely underreported in many countries because of a lack
of diagnostics and surveillance systems [9, 17]. In 2016 alone, the CDC reported 6,100
confirmed cases of Legionnaires’ disease in the United States and acknowledged that this
number may be higher because of undiagnosed disease [18]. In many cases, when
patients present with pneumonia, they are treated with antibiotics and no lab diagnostic
tests are performed to determine the causative agent of the pneumonia. Urine-ELISA
assays are needed to confirm Legionella infections but are becoming more commonly
performed [19-21]. Without consistent patient testing, it is difficult to confirm the number
of Legionnaires’ disease cases annually. Importantly, roughly 50% of pneumonia cases
are of unknown etiology [21], suggesting that L. pneumophila may be responsible for
more cases then is currently appreciated.

Epidemiology of L. pneumophila
L. pneumophila are aquatic organisms globally distributed and natural bodies of
water serve as the natural reservoir. As a result, Legionnaires’ disease remains an
important public health problem worldwide. Outbreaks of L. pneumophila is thought to
have emerged in the 20th century because of alterations to the environment by humans
that generate water aerosols that act as a vehicle to transmit L. pneumophila from
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different water sources [4]. Some of these sources include air conditioning systems,
cooling towers, grocery store misters, humidifiers, and hot tubs[4]. Generally, infection
starts with the inhalation of contaminated aerosolized water droplets [22-25]. Until
recently, it was widely accepted that L. pneumophila was exclusively transmitted in this
manner [27]. A single recent case in Europe is the only report of person-to-person
transmission [27]. The conditions surrounding this case aided in transmission from one
person to another. In this case, an individual was taking care of a seriously ill close
relative where frequent and lengthy exposure occurred leading to the transmission of L.
pneumophila [26-28]. Thus, water serves as the natural reservoir for L. pneumophila and
serves as the only source of transmission.
L. pneumophila can be controlled in water handling systems with proper
maintenance. While this is simple enough, many water handling systems and water
holding units are not properly cared for. This is a wide-spread problem which was
illustrated by a study through the CDC that identified Legionella DNA in 84% of cooling
towers tested in the United States [29]. For eradication, continual water treatment is
required. Treatments include keeping hot tank water temperatures above 55 ºC and
treatment with either monochloramine, chlorine dioxides, or copper-silver ions [30-32].
Short term interventions are the common method for treatment of contaminated water
sources including biocides, overheating of water or single treatments using UV
irradiation, but these methods are not successful for eradicating the bacteria from water
sources [30, 31, 33].
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Ecology of L. pneumophila and its Adaptation to Protoza
The natural reservoir for L. pneumophila is water; and this bacterium has been
found in many freshwater environments, and in many man-made water systems, in close
association with freshwater protozoa. Legionnaires’ disease has only recently emerged
because of human alterations to the environment which result in optimal conditions to
support replication of the organism [4, 34]. When L. pneumophila are left in their natural
aquatic environment it is unlikely that they would cause disease; and natural water
environments have never been implicated in Legionnaires’ disease outbreaks [4].
Protozoa are an important reservoir for L. pneumophila, and in aquatic
environments, these bacteria parasitize and replicate within amoebae. There are 17
known species of amoebae and 7 species of non-amoebal protozoa that are capable of
supporting L. pneumophila growth [35-49]. L. pneumophila infects the trophozoite form
of amoebae and serves to protect the bacteria [50]. Amoebae do not only play an
important role in enhancing the pathogenicity of L. pneumophila, enable the bacteria to
persist in the environment thereby contributing to the pathogenesis of Legionella.
The ability to infect human macrophages is hypothesized to be a consequence of
the prior adaptation of L. pneumophila to the intracellular life within the various
protozoan hosts [51]. Respirable sized vesicles are released from protozoa, which contain
bacteria that are highly resistant to biocides while the vesicles themselves are resistant to
sonication and freezing [52]. When released from a protozoan host, L. pneumophila
exhibits an enhanced ability to infect mammalian cells as well as being more invasive to
cells [53]. L. pneumophila grown in protozoa show changes in biochemistry, physiology,
and virulence potential relative to those grown in vitro [54].These changes include an
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increased resistance to antibiotics, biocides, disinfectants and harsh conditions as well as
altered fatty acid and protein profiles, decrease in size and motility, an increased ability to
infect amoeba and mammalian cells, an increase in environmental fitness, and an increase
in uptake via coiling phagocytosis [55-62]. During outbreaks, L. pneumophila and
amoebae have been isolated from the same source of infection and these amoebae have
been shown to support the growth and replication of L. pneumophila [63]. Some L.
pneumophila that cannot be isolated using classical culturing methods have been
culturable if in the presence of protozoa [51].
When conditions become unfavorable, protozoa can differentiate from their
trophozoite form into a cyst form that protects the organisms and ensures their survival.
L. pneumophila has also been shown to survive within amoebic cysts [64].This
differentiation is a highly resistant developmental stage for the amoebae and contributes
to the resistance of L. pneumophila to different chemical and physical agents [65].
Environmental stress plays an important role in the transition of L. pneumophila
from environmental bacteria to an intracellular pathogen [66]. The relationship between
L. pneumophila and amoebae plays an important role in the pathogenicity of the
bacterium [67]. Contributing to the pathogenesis of Legionella, a great deal of evidence
shows that growth of bacteria in amoebae also plays a role in transmission. First, there is
no transmission of L. pneumophila between individuals under normal circumstances.
Second, the number of free bacteria isolated from the environmental sources of
Legionnaires’ disease infections is usually low or undetectable [68]. Third, protozoa
release respirable sized vesicles that contain L. pneumophila [52]. Fourth, the bacteria
exhibit an enhanced ability to infect mammalian cells after being released from a
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protozoa host [53]. Perhaps because L. pneumophila that has been grown in amoebae is
more motile and invasive [52]. Fifth, the bacteria grown in a protozoan host show
increased resistance to chemical disinfectants, biocides and antibiotics, which makes the
bacteria better at establishing disease then free-living amoebae [60-62]. Sixth, bacteria
also show an increased resistance to harsh conditions compared to those grown in vitro
[59]. Seventh, bacteria and amoebae have been isolated from the same source of infection
during outbreaks [63]. Lastly, L. pneumophila that cannot be cultured using classical
methods can be cultured if they are co-cultured with protozoa [51, 69].
There are Legionella-like species that cannot be grown on bacteriologic media but
must be co-cultured with protozoa and are referred to as Legionella-like amoebal
pathogens (LLAP). LLAPs are closely related to Legionella phylogenetically and
acquired their name because of their ability to infect and multiply within amoebae [70].
The genes that code rRNA in bacteria are highly conserved and are often used to compare
the relatedness of different organisms. When comparing LLAPs rRNAs to those of L.
pneumophila, LLAP rRNA shows 91.6-95.8% similarity to L. pneumophila rRNA
indicating there is a phylogenetic relationship between the two organisms [70]. The
LLAPs play a role in community-acquired pneumonia, usually as a co-pathogen and
rarely as the sole pathogen [71]. LLAPs are remain a mystery and future studies sre
needed to gain a better understanding of the significance of these organisms to human
health.
Numerous methods have been employed to attempt to eradicate L. pneumophila
from aquatic environments. These attempts, which include chemical biocides,
overheating water and UV irradiation, have been successful for short periods after which
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the bacteria can be again detected. It has been suggested that to eradicate L. pneumophila
from aquatic environments treatments should be continuous and effective against both the
bacteria and the protozoa host [51, 54, 65]. These findings support the hypothesis that
amoeba play a key role in the ecology and pathogenesis of L. pneumophila and
demonstrate the close and unique relationship between the two organisms.

Intracellular life cycle of L. pneumophila within Amoebae and Macrophages
The infection of human phagocytic cells occurs when an individual inhales
contaminated aerosolized water [4]. Once L. pneumophila infects a human host it enters
alveolar macrophages where the intracellular life cycle is strikingly similar to the life
cycle observed when amoebae engulf L. pneumophila (Figure 1-1) [4]. The mode of
uptake for both macrophages and amoeba has been described as coiling phagocytosis [72,
73]. Once inside the host cell the bacteria can be found inside a unique replicative
vacuole whose biogenesis does not follow the endosomal-lysosomal degradation pathway
[74]. This vacuole is termed the L. pneumophila containing vacuole (LCV). The LCV is
associated with ribosome-studded membranes of the host cell endoplasmic reticulum [4].
Within the LCV, L. pneumophila replicates in high numbers which causes the LCV to
rupture releasing the bacteria into the host cell cytosol where another 1-2 rounds of
replication occur. During these final stages of replication, the bacteria become flagellated
and virulent [51, 75, 76]. The final stage in the L.pneumophila intracellular lifecycle is
lytic of the host cell and release of bacteria [77-79]. This cycle is repeated once the
bacteria infects new host cells in the lungs.
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Figure 1-1: The environmental life cycle of L. pneumophila. (1) Flagellated L.
pneumophila infect protozoa in the aquatic environment. (2) The LCV evades the default
endosomal–lysosomal degradation pathway and becomes rapidly remodeled by the ER
through intercepting ER-to-Golgi vesicle traffic and becomes rapidly decorated with
polyubiquitinated proteins in an AnkB-dependent manner. (3) Under unfavorable stress
conditions, such as nutrient deprivation, amoebae encyst and bacterial proliferation will
not occur due to nutrient limitation. Under growth-permissive conditions for the
amoebae, the LCV is decorated with polyubiquitinated proteins, which are targeted for
proteasomal degradation leading to elevated cellular levels of amino acids (AA) that
power bacterial proliferation of the wild-type strain, while the ankB mutant is defective in
this process and is unable to grow despite formation of ER-remodeled replicative LCV.
(4) During late stages of infection, the LCV becomes disrupted leading to bacterial egress
into the cytosol where the last 1–2 rounds of proliferations are completed. Upon nutrient
depletion (see magnified box), RelA and SpoT are triggered leading to increased levels of
ppGpp, which triggers phenotypic transition into a flagellated virulent phenotype
followed by lysis of the amoeba and bacterial escape from the host cell. Excreted vesicles
filled with bacteria are also released. The infectious particle is not known but may
include excreted Legionella-filled vesicles, intact Legionella-filled amoebae, or
free Legionella that have been released from host cell. (5) Transmission to humans occurs
via aerosols generated from man-made devices and installations, such as cooling towers,
whirlpools, and showerheads [80]. Adapted from Richards et al 2013 [79].

Biphasic Life Cycle of L. pneumophila
The intracellular lifecycle of L. pneumophila consists of a replicative phase,
within the LCV, and a transmissive phase, exhibited upon escape into the cytosol [75, 8183]. This biphasic lifestyle is characterized by dramatic changes in gene expression and
phenotypes [84, 85]. During the replicative phase, the bacterium is undergoing
exponential (E) growth, it is non-motile, avirulent, sodium resistant and represses its
transmissive traits [86, 87]. A ‘stringent-like’ response pathway is triggered upon
transition of L. pneumophila into post-exponential (PE) growth. The bacteria become
virulent, cytotoxic, motile, and capable of lysosomal evasion. These changes are
necessary to invade a new host and start a second cycle of proliferation [58, 88].
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Transcriptional analysis of L. pneumophila during infection of Acanthamoeba castellanii
showed that these two phases exist both in vivo and in vitro [85].
Replicative to transmissive phase transition is triggered by nutrient limitation and
is a highly orchestrated event involving many factors [75, 76, 89]. Upon amino acid
depletion, uncharged tRNAs activate RelA to synthesize the bacterial alarmone 3’,5’bispyrophosphate (ppGpp), a master regulator of numerous genes of L. pneumophila
pathogenesis, which triggers differentiation into the post exponential (PE) phase [90, 91].
RpoS and several global response two-component regulators, such as LetA/S [76, 92-94],
are required for phenotypic transition at the PE phase while the RNA-binding protein
CsrA acts as a global repressor of the transition and needed later for replication [95]. Two
small, non-coding RNAs, RsmY and RsmZ, are induced by LetA at the stationary phase
to relieve the repression of CsrA from target genes, required to avoid lysosomal
degradation [76, 87]. The ppGpp synthetase RelA monitors amino acid availability
through its association with the ribosome [96] and works in conjunction with SpoT, a
bifunctional synthetase/hydrolase that responds to fatty acid starvation, to control levels
of ppGpp [96]. DskA, a RNA polymerase (RNAP) secondary channel interacting protein,
mediates the physiological effects of ppGpp through interactions with RNAP [97].
Without DskA, L. pneumophia is defective in stationary phase survival, flagellar gene
activation, lysosomal avoidance, and macrophage cytotoxicity [96].

The Type II Secretion System (T2SS)
There are 8 secretion systems that Gram-negative bacteria possess that permits the
export of bacterial proteins from within the bacteria to the target host cell or into the
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extracellular milieu [98]. L. pneumophila codes for two distinct secretion systems, type 2
and type 4, both of which contribute to the pathogenesis of the bacterium [99-101]. The
Type 2 secretion system (T2SS) exists in many Gram-negative bacteria including both
plant and animal pathogens.
The T2SS is composed of 12 core proteins with 4 subcomplexes. The first
subcomplex is an outer membrane “secretin” which provides a pore through the
membrane, second is an inner membrane platform which provides a connection to the
secretin, third is a cytoplasmic ATPase which gets recruited to the inner membrane
platform, and lastly is a periplasm-spanning pseudopilus [99, 102-104]. The T2S consists
of a two-step process where proteins that are destined to be secreted are first trafficked
into the periplasm, across the inner membrane of the bacteria by the Sec pathway or the
Tat pathway [102]. The second step is responsible for secreting proteins that are
recognized by the secretion apparatus to the extracellular milieu via an outer membrane
pore [102]. The L. pneumophila T2SS is important for intracellular infection in host cells
and amoebae, as well as growth in mouse models of disease [105-108]. Nearly all
pathogens that express the T2SS system exist within aquatic and soil environments in
addition to their higher organism hosts [102]. The Legionella type 2 secretion (Lsp)
system, plays a major role in the infection of amoeba and is involved in promoting
bacterial replication in at least four genera of amoebae [46, 100, 104, 109, 110]. The
T2SS system functions at a temperature range of 22-37°C, temperatures commonly
associated with aquatic niches thus implicating the T2SS system as being necessary for L.
pneumophila survival in the environment [107].
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To date, 25 proteins have been identified as substrates of the T2SS, many of
which are enzymes responsible for degrading proteins and lipids as well as some proteins
with novel functions [102]. The effector substrates of the T2SS system increase the
likelihood of infection of amoebae with L. pneumophila. These effectors include the
acyltransferase PlaC, ribonuclease SrnA, metalloprotease ProA, and two novel proteins –
NttA and NttC [46, 104, 105, 111]. Each effector is important for infection and their
importance varies depending on the species of amoebae. This suggests that the repertoire
of L. pneumophila effectors secreted by the T2SS system has evolved to enhance the
broad host range of this bacterium.
Various studies have considered the importance of the T2SS system in relation to
its ability to survive in aquatic environments either as part of a multi-organismal biofilms
or planktonically [106, 111-115]. One study from Söderberg et al [106] has shown that
T2SS mutants show a decreased ability to survive extracellularly in tap water samples
that have been incubated at a temperature range of 4-25°C [107, 112]. The secretome of
L. pneumophila changes in relation to temperature changes, which suggests there are
effectors secreted by the T2SS that facilitate survival in low temperatures [107, 112]. It
has also been shown that mutants lacking the T2SS Lcl protein are not able to form
biofilms as efficiently as bacteria containing a functional T2SS system [113]. Lastly, it
was shown that T2SS systems mutants have impaired gliding motility, which is likely the
result of an inability to secret a novel surfactant [114-116].
While evidence shows the T2SS is important for infection of amoebae and
persistence in the aquatic environment, it also aids in L. pneumophila growth within the
lung. For example, T2SS mutants show impaired growth within the mouse and Guinea
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pig disease models [106, 109, 117]. Studies have shown that the T2SS is not required for
entry of L. pneumophila into alveolar macrophages, nor is it required for the evasion of
the host phagosome-lysosome degradation pathway but is required for bacterial
replication at 4-8 hours post infection and for the ability to replicate to large numbers
within the LCV at and beyond 12 hours post infection [108]. The T2SS is responsible for
dampening the cytokine output of infected macrophages as well as the secondary host
during infection, epithelial cells [117]. The T2SS suppression of the innate immune
response is hypothesized to limit inflammatory cell infiltrates into the lung initially,
which aids in prolonged bacterial growth [118]. The intracellular localization of T2SS
substrates is unknown for many of the substrates secreted via this system [119]. It has
been suggested that T2SS are not restricted to the LCV lumen due to the observation that
T2SS mutants show an impaired ability to retain Rab1B on the LCV, which suggests that
a T2SS substrate may exit the LCV where it can engage host GTPases in the cytoplasm
[119]. It has also been shown that T2SS mutants trigger immune response pathways, like
MyD88 and Toll Like receptor 2, resulting in an increase in inflammatory cytokine levels
and suggesting T2SS effector proteins dampen cytosolic innate immunity sensors [118,
120]. A recent study by Truchan et al elucidated the cellular localization of 2 T2SS
effectors, ProA (a metalloproteinase) and ChiA (chitinase), which escape the LCV and
then form a ring-like pattern around the LCV membrane in the host cell cytosol [121].
These studies help to shift views from the predominant paradigm in the L. pneumophila
field, which is that only type 4 secretion system (T4SS) effectors are able gain access to
the host cell cytoplasm during infection [121].
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The Dot/Icm Type 4 Secretion System
While there is still much to learn about the T2SS, more is known about the T4SS.
The Dot/Icm T4SS system is an important virulence system that is involved in almost all
aspects of the intracellular biology of L. pneumophila [122]. This set of roughly 30 genes
were named dot (defective in organelle trafficking) or icm (intracellular multiplication)
[123-129]. The Dot/Icm system, which is classified as a T4SS system because of its
similarity with conjugation systems, is composed of 27 proteins that form a syringe-like
apparatus responsible for translocating effector proteins from the inside the bacteria
across the LVC membrane into the host cell cytosol [130, 131]. This system is
responsible for translocating ~330 effector proteins into the host cell cytoplasm with the
help of a secretion system coupling complex comprised of DotL, DotM, and DotN [132].
DotL, DotM, and DotN form a coupling complex that is responsible for recruiting protein
substrates in the bacterial cytoplasm and delivering them to the translocation channel in
the inner membrane [132]. This complex works in association with three chaperone
proteins, IcmW, IcmS and LvgA, which recruit some of the substrates to DotL via a 20amino acid region translocation sequence located within the C terminal portion of the
protein [130, 132-136]. This need for a chaperone is not the case for all effectors as some
can still bind to the coupling complex without the help of the chaperone proteins [132].
The ~330 substrates of the Dot/Icm system are known as effector proteins, which
accounts for approximately 10% of the L. pneumophila genome coding capacity [137140]. L. pneumophila contains the largest repertoire of effector proteins, followed by
Coxiella burnetii which contains ~100 effector proteins [141]. Some of the L.
pneumophila effector proteins are translocated upon attachment of the bacterium to a host
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cell, but the translocation of these proteins occurs throughout the intracellular growth
phase of the bacteria [142, 143]. RalF was the first effector shown to be translocated from
the bacteria to the host cell in a Dot/Icm dependent manner [144]. Since the discovery of
RalF, numerous other effectors have been identified that have been shown to play roles in
modifying host cell processes in order to establish a replicative niche that supports robust
replication of L. pneumophila. Some of the better characterized examples of effectors
whose functions have been identified play roles in vesicular trafficking pathways (LidA
& AnkX), host protein synthesis (Lgt1 & Sidl), cell apoptosis (SdhA & SidF), and host
ubiquitination pathways (AnkB & LubX) [145-151].
The accumulation of the alarmone ppGpp increases mRNA for T4SS components,
secreted host regulators, and effectors [96]. Many of the substrates for the T4SS are
strongly upregulated during the transmissive phase [152]. Many of the effectors
upregulated during this phase of growth are involved in inhibition of phagosome
maturation, altering trafficking and proteins involved in egress from the amoeba [152].
An important effector molecule for intracellular survival and replication of L.
pneumophila is the eukaryotic-like protein AnkB which is temporally and differentially
regulated at the PE phase by RelA [56]. AnkB is injected into the host cytoplasm by the
Dot/Icm system immediately upon bacterial attachment to the plasma membrane, and
anchors into the LCV [54, 150]. Where it plays a role in creating nutrients required for L.
pneumophila survival and replication.
The Dot/Icm system is located at the poles of the bacteria, which is an important
for the bacteria since studies have shown that non-polar localization results in the failure
of lysosomal evasion by L. pneumophila [153]. While this system is responsible for
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translocating many substrates, only 2-4 Dot/Icm apparatus complexes have been
identified at the poles of the LCV [153]. Not all effectors are translocated at the same
concentration or point during infection, which could be a result of the number of
apparatuses located on the LCV [154, 155].

Functional Redundancy of Effector Proteins
Deletion of very few effector proteins result in intracellular growth defects in
macrophages of L.pneumophila, which is likely the result of functional redundancy
among the effector repertoire [156-158]. One explanation for functional redundancy is
that over time, L. pneumophila has acquired a toolbox of effector proteins as a result of
inter-kingdom horizontal gene transfer. Different effectors are likely specific for infection
of specific hosts, which explains why deletion of effectors does not result in a growth
defect in macrophages. Eliminating up to 31% of the effectors has been shown to barely
cause any replication defects in mouse macrophages [158].
Effector redundancy occurs via different mechanisms including pathway
redundancy, cellular process redundancy, target redundancy, molecular redundancy and
system redundancy [156]. Redundant effector proteins have been shown to perform the
same function in host cells and interact with the same host cell targets. One well
characterized example of this is the SidE family of effectors [157]. The SidE family
consists of four effector proteins (SidE, SdeA, B, and C) which function to catalyze the
addition of ubiquitin moieties to the host proteins Reticulon 4 and Rab33b [159, 160].
When each of these effectors are individually deleted, there is no replication defect
detected, but when all four effector proteins are deleted there is a significant decrease in
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intracellular replication of L. pneumophila, which can be restored with complementation
of SdeA alone [160, 161]. An example of pathway redundancy is that of VipD and SidK,
both of which target different components of the host endocytic pathway [154, 162].
Effectors that show redundancy in targets include SidM and AnkX, both of which
modulate Rab1 activity but through different mechanisms [163-165]. SidF and SidP are
two examples of effectors that show cellular process redundancy as both effectors
modulate host lipid metabolism and phosphoinositide abundance at the LCV by targeting
redundant or complementary host pathways governed by a single process [156, 166, 167].
Lastly, system redundant effectors are effectors that are responsible for modulating more
than one cellular processes in host cells in order to accomplish the same task. Examples
of this include LegK1, that activates NF-κB by degrading IκB, Lgt1/2/3 blocks host
protein synthesis by restoring IκB, and SidF, which inhibits the host pro-apoptotic
proteins [165, 167]. These effectors work to satisfy the end goal of inducing mechanisms
of host cell survival [146, 166, 168].

Genome Plasticity
A hallmark of the L. pnumophila genome is its low GC content. The GC content
of the L. pneumophila genome is roughly 38.3% and the GC content of protozoan
genomes is also similarly low [169]. The long-term co-evolution of L.pneumophila with
different protozoan hosts has likely affected genome structure of this bacteria primarily
through inter-kingdom horizontal gene transfer (HGT) [89, 170-173]. A high degree of
plasticity is observed even between strains of the same species of L. pneumophila [169].
When comparing the L. pneumophila strains Paris and Lens, there are 2,664 genes
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conserved but 428 and 280 are strain-specific, respectively [169]. Different potential “hot
spots” for genomic rearrangement that contribute to the plasticity of Legionella have been
identified [169, 174]. Some L. pneumophila strains contain plasmids that have been
inserted into the chromosome, which has also contributed to the plasticity of the genome
[169].
Co-evolution of L. pneumophila with amoebae and other protozoan hosts has
likely contributed to the plasticity of the genome. L. pneumophila is naturally competent
and is capable of natural transformation of DNA uptake through conjugation machinery
[67, 129, 175]. Amoebae have possibly played the role of a melting pot for L.
pneumophila which has resulted in long term convergent evolution and gene modification
via HGT, which probably explains both the genome plasticity, large repertoire of effector
proteins, effectors containing eukaryotic-like domains and motifs, as well as effector
redundancy of the organism [169, 171, 176].

Eukaryotic-Like Proteins of L. pneumophila and their Origin
L. pneumophila harbors a plethora of eukaryotic-like effectors that interfere with
host processes by mimicking eukaryotic functions. One of the best described examples of
effector proteins with conserved eukaryotic domains that are necessary for intracellular
proliferation of L. pneumophila is AnkB [54, 150, 177]. The AnkB protein consists of
Ankyrin domains (ANK), an asparagine hydroxylation motif, a eukaryotic CaaX motif
(“C’ cysteine, “a” aliphatic amino acid, “X” any amino acid), and an F-box domain [177180]. Ankyrin repeat domains are 33-amino acid domains that primarily function as
scaffolds to mediate protein-protein interactions [181, 182]. These domains are
responsible for targeting effector proteins in the host and are one of the most versatile
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domains present in Legionella effectors [137, 138]. The CaaX motif allows the protein to
be farnesylated, which is a highly conserved posttranslational modification that confers
hydrophobicity allowing the lipidated protein to be anchored in membranes [183].
Another example of an effector of L. pneumophila that hijacks conserved host eukaryotic
systems is the SidE family of effectors. This family of effectors exploits the
ubiquitination machinery and specifically ubiquitinates Reticulon4 and Rab33 [158, 159].
Reticulon4 and Rab33 do not have homologs in all species of protozoa that can be hosts
for L. pnueumophila and only a few have Rtn4 and Rab33 homologs indicating the SideE
family has host-specific functions [208]. Many of these translocated effectors are
functionally and structurally similar to eukaryotic proteins and interact with various
eukaryotic processes such as signaling, protein synthesis, apoptosis, posttranslational
modification, vesicular trafficking, ubiquitination, and proteasomal degradation [57,
184].
The long-term coevolution of L. pneumophila with various protists and metazoa
has influenced the genomic structure of the bacteria through inter-kingdom HGT.
Translocated effectors contain many motifs and domains normally found only in
eukaryotic proteins. Long term modification of the acquired host genes through cquisition
of prokaryotic promoters and regulators, as well as translocation motifs is essential to
evolve the proteins to become functionally active effectors in the host cell [159]. A good
example is AnkB. The F-box domain of AnkB contains the ANK domain which is
common for amoeba F-box proteins but not for mammalian F-box proteins indicating
AnkB was likely acquired from a primitive eukaryotic host [89, 180, 185]. It is to be
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expected that many of the eukaryotic-like proteins are still undergoing modifications that
might allow for them to be translocated and/or to act as effector proteins [89].
Domain shuffling has also played a major role in the evolution of Legionella
effector proteins. Two recent studies, one conducted by Burstein et al. and one conducted
by Gomez-Valero et al., analyzed the genomes of multiple species of Legionella [137,
138]. The Burstein study identified and analyzed effector proteins in 41 Legionella
genomes. Analysis was performed using two criteria – first was the similarity to known
domains in a domain database, and the second was the conservation of effector regions
across orthologous groups of effectors [137]. The group identified 99 distinct domains
including 53 well characterized domains and 46 new conserved domains. Next, they
analyzed protein architecture, or domain combinations, and found that the same domains
were commonly present in different architectures or combinations [137]. The GomezValero study expanded on the data found in the Burstein study [137]. This group
sequenced 58 Legionella species and analyzed them with publicly available genomes (80
genomes total) [138]. This group identified a total of 137 different eukaryotic
motifs/domains present in the strains studied. Both studies found that the Ankyrin repeat
domain (ANK) was the most common domain [137, 138]. This domain appeared in
combination with a variety of other domains and architectures across the Legionella
genome. Over 300 Legionella effector proteins contain an ANK domain [137, 138].
Ankyrin repeats commonly appear in combination with other protein domains in
numerous effector proteins [137, 138]. Some Ankyrin repeats are found in combinations
that are species-specific effectors in Legionella, while others were conserved across the
genus.
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L. pneumophila has an extraordinary number of effectors that are in its toolbox
and are the probable source of ability of L. pneumophila to exploit many host processes
within many different amoebae hosts, thus effectively increasing its fitness as a generalist
pathogen [89]. Long term coevolution of L. pneumophila with its protozoan hosts and
inter-kingdom horizontal gene transfer has likely resulted in an accidental ability to cause
disease in humans, perpetuated by changes in human lifestyle.

Understanding its

association with amoeba will give us a better understanding of how L. pneumophila is
able to cause disease though the exploitation of evolutionary conserved eukaryotic
processes.

Core Effectors of L. pneumophila
In total, Burstein et al. identified 5,885 putative effectors present within the
Legionella genus [137]. Legionella genes that consisted of ≥ 80% predicted effectors
were split into orthologous groups which were designated Legionella effector ortholog
groups (LEOGs) [137]. A total of 608 LEOGs were identified and it was observed that
most of the LEOGs were shared by a small subset of species. Roughly 63% of the
effector repertoire (3,715 effectors in 269 LEGOs) consisted of orthologs of validated
effectors from L. longbeachae and L. pneumophila. The remainder (2,170 effectors in
339 LEGOs) represent new putative effectors which may show novel functionality [137].
The study conducted by Gomez-Valero et. al. identified roughly 18,000 effector proteins
representing more than 1,600 orthologous groups [138].
Interestingly, both studies only identified seven core effectors. The study
conducted by Gomez-Valero et al. also identified one other effector that was not included
in the search by Burstein et al. which brings the total number of core effectors to eight.
23

[137, 138]. Six of the 8 core effectors are conserved among all species of Legionella,
sequenced. One effector (MavN) had orthologs in all the sequenced Legionella as well as
one other bacterium encoding the DOT/ICM T4SS, Rickettsiella gyrlli [137].
Remarkably, only one of the core effectors (AnkH/LegA3/Lpg2300) is not only
conserved across the Legionella genus but also contains orthologs in other organisms
containing the Dot/Icm T4SS, including Coxiella burnetii and Rickettsiella grylli [137,
138]. The conservation of the AnkH effector among bacterial species encoding the
Dot/Icm T4SS indicated that it is involved in modulating host cell processes that are
evolutionarily conserved and required by various intracellular pathogens.

Structure of AnkH and its role in the intracellular survival and replication of L.
pneumophila

The AnkH effector is a 467-amino acid protein that contains four eukaryotic-like
ANK domains [186]. Previous studies in the Abu Kwaik lab have established that AnkH
is successfully translocated into the host cell cytoplasm [187]. This effector is required
for intracellular replication within multiple host cells, including human monocyte-derived
macrophages (hMDM), Acanthamoeba polyphaga, Hartmanella vermiformis, and for
intrapulmonary proliferation in the mouse model of infection [186, 187]. This replication
defect as a result of deletion of ankH has been shown using both colony forming units
(CFUs) and confocal microscopy. With the later, we have shown that when cells are
infected with a L. pneumophila strain lacking the AnkH effector (∆ankH), the LCV
contains fewer bacteria than the LCV of cells infected with the wild type strain [187].
The ∆ankH mutant is rescued by complementation and can also be trans-rescued in
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eukaryotic cells transfected with the ankH gene [186]. This was also the case when the
∆ankH mutant shared communal or distinct LCVs within the same cell as the WT strain
during co-infection studies [187].
When cells are infected with the ∆ankH strain, the LCV biogenesis and its fusion
to ER-derived vesicles is indistinguishable from the LCV harboring the WT strain. When
AnkH is ectopically expressed, there was no significant difference observed between the
association of the tagged AnkH protein with trafficking markers including Lamp2,
cathepsin D, GM130, KDEL actin, tubulin, or mitochondrial protein [186] (Figure 1-2).
In addition to ANK repeats, there have also been two asparagine hydroxylation
motifs identified within AnkH [179]. The crystal structure of AnkH has revealed two Asn
hydroxylation motifs, four ANK domains, as well as a cysteine-like protease domain and
a CAP domain [188]. We have previously shown that two of the ANK domains are
required for proper function of the protein, since deletion of either domain results in an
intracellular replication defect [185]. It has also been shown that one of the asparagine
hydroxylation motifs is hydroxylated (at N59) and the motifs are required for proper
function of AnkH [179]. Overall, previous data has shown that AnkH is an important
effector for L. pneumophila and defining the function of AnkH during infection would
result in a better understanding of the pathogenesis of L. pneumophila.
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Figure 1-2: AnkH is not involved in LCV formation or evasion of host
degradation pathways. Once engulfed by the host cell (1), LCVs harboring the
WT or ankH mutant strain inhabit similar LCVs which evade the host endosomelysosome degradation pathway (2) and go on to intercept ER derived vesicles that
help to create a replicative niche for the bacterium (3).
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SPECIFIC AIMS
L. pneumophila has spent a considerable amount of time co-evolving with
primitive eukaryotic organisms resulting in a plethora of effectors with eukaryotic like
protein domains. These protein domains are found dispersed among L. pneumophila
effector proteins resulting in a toolbox that aids in the infection of specific L.
pneumophila host organisms. Many of the ~330 effector proteins translocated by L.
pneumophila contain eukaryotic-like protein domains demonstrating the importance of
these domains in the function of many of the effectors, which contributes to intracellular
survival of L. pneumophila. Ankyrin repeat domains were identified as the most
commonly occurring eukaryotic-like protein domain among effectors in the Legionella
genus [136, 137]. Ankyrin repeat domains are involved in protein-protein interactions
and act as a scaffold for these interactions [180, 181]. L. pneumophila contains 11
effector proteins containing ANK domains [186]. One of the ANK domain containing
effector proteins, AnkH, has been shown to be required for intracellular replication of L.
pneumophila in amoebae, human macrophages, and for intrapulmonary proliferation in
the mouse model of infection. The crystal structure revealed that AnkH consists of four
ANK domains, a cysteine-like protease domain, two asparagine hydroxylation motifs,
and a cap domain [188]. The Legionella genus codes for ~18,000 effector proteins. Of
those effector proteins, AnkH is the only effector that is conserved among all sequenced
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Species of Legionella as well as among organisms that contain the Dot/Icm T4SS [137,
138].
I hypothesize that the AnkH effector interacts with a specific highly conserved
host target and modulates an evolutionarily conserved process in eukaryotic cells.
This hypothesis will be tested through three specific aims:

Specific Aim 1: Identify the host-cell interacting partners for AnkH.

Specific Aim 2: Identify downstream cellular processes altered by the interaction
between AnkH and its host cell target proteins.

Specific Aim 3: Determine the role of various domains and motifs of AnkH in its
function.
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CHAPTER 2:
INTERACTION OF THE ANKYRIN H CORE EFFECTOR OF LEGIONELLA WITH
THE HOST LARP7 COMPONENT OF THE 7SK SNRNP COMPLEX*

___________________
* Von Dwingelo, J., Chung, I., Price, C.T., Li, L., Jones, S., Cygler, M., Abu Kwaik, Y.
Interaction of the Ankyrin H Core Effector of Legionella with the Host LARP7
Component of the 7SK snRNP Complex. mBio, 2019, 10(4) e01942-19; DOI:
10.1128/mBio.01942-19
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Summary
The Legionella genus encode at least 18,000 effector proteins that are translocated
through the Dot/Icm type IVB translocation system into macrophages and protist hosts to
enable intracellular growth. Eight effectors, including Ankyrin H (AnkH), are common to
all Legionella species. The AnkH effector is also present in Coxiella and Rickettsiella. To
date, no pathogenic effectors have ever been described that directly interfere with host
cell transcription. We identified the host nuclear protein LARP7, which is a component
of the 7SK snRNP complex, to interact with AnkH in the host cell nucleus. The AnkHLARP7 interaction partially impedes interaction of the 7SK snRNP components with
LARP7, interfering with transcriptional elongation by Pol II. Consistent with that, our
data show AnkH-dependent global reprogramming of transcription of macrophages
infected by L. pneumophila. The crystal structure of AnkH shows that it contains Nterminal four ankyrin repeats, followed by a cysteine protease-like domain and an αhelical C-terminal domain. A substitution within the β-hairpin loop of the third ankyrin
repeat results in diminished LARP7-AnkH interactions and phenocopies the ankH null
mutant defect in intracellular growth. LARP7 knockdown partially suppresses
intracellular proliferation of WT bacteria and increases severity of the defect of the
∆ankH mutant indicating a role for LARP7 in permissiveness of host cells to intracellular
bacterial infection. We conclude that AnkH-LARP7 interaction impedes interaction of
LARP7 with 7SK snRNP, which would block transcriptional elongation by Pol II leading
to host global transcriptional reprogramming and permissiveness to L. pneumophila.
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Importance
In order for intracellular pathogens to thrive in host cells, an environment that
supports the survival and replication needs to be established. L. pneumophila
accomplishes this through the ~330 effector proteins that are injected into host cells
during infection. Effector functions range from hijacking host cells trafficking pathways
to altering host cell machinery resulting in altered cell biology and innate immunity. One
such pathway is the host protein synthesis pathway. Currently, 5 L. pneumophila
effectors have been identified that alter host cell translation while only 2 effectors have
been identified that indirectly affect host cell transcription. To date, no pathogenic
effectors have ever been described that directly interfere with host cell transcription. Here
we show direct interaction of the AnkH effector with a host cell transcription complex
involved in transcriptional elongation. We identify a novel process by which AnkH
interferes with host transcriptional elongation through interference with formation of a
functional complex and this interference is required for pathogen proliferation.
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Introduction
Legionella pneumophila is a Gram-negative intracellular pathogen that is
ubiquitous in freshwater environments [189] where it primarily parasitizes a wide range
of protozoan hosts, which serve as the bacterial natural hosts [40, 190, 191] and
contribute to pathogenesis and ecology of the pathogen [4, 50, 65, 192]. When humans
encounter contaminated water sources, aerosolized water droplets can be inhaled and
reach the lung where bacteria can invade and proliferate within alveolar macrophages,
causing pneumonia [193]. To date, approximately 65 species of Legionella have been
identified with almost half of the species capable of causing disease in humans [137, 138,
194, 195]. L. pneumophila in particular is responsible for 90% of Legionnaires disease
cases globally [8].
The life cycle of L. pneumophila within amoebae and alveolar macrophages, is
strikingly similar [196-201]. After the bacteria are engulfed by the cell, ER-derived
vesicles fuse to the phagosome to generate the Legionella-containing vacuole (LCV)
[198, 200, 202, 203], which evades the host endosomal-lysosomal degradation pathway
but communicates with early secretory vesicle trafficking pathways [156, 204].
Biogenesis of the LCV is dependent on the Dot/Icm type IV secretion system that is
responsible for translocation of at least 330 effector proteins into the host cell cytoplasm
[205, 206]. The injected effectors interact with specific host targets to modulate a
plethora of host cell processes that remodel the macrophage and amoeba host into a
proliferative niche [205, 207-209]. In most cases, the deletion of a single L. pneumophila
effector gene does not result in a growth defect in mammalian macrophages or amoeba
[158]. Although this is thought to be due to redundancy, it is more likely that many of
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this arsenal of effectors are host-specific and constitute a “toolbox” from which specific
tools are utilized in specific environmental eukaryotic hosts [156, 210]. Genomic analysis
of 58 Legionella species have shown that the legionella genus has ~18,000 effectors but
only 8 of these effectors (MavN, VipF, RavC, CetLp1, lpg2832, lpg3000,
lpg1356/lpp1310 and AnkH/LegA3/Lpg2300) are conserved among all Legionella
species and are designated as core effectors [137, 138]. Of the 8 core effectors, AnkH is
the only effector conserved among all bacterial pathogens harboring the Dot/Icm T4SS,
including Coxiella burnetii and Rickettsiella grylli [137, 138]. It is therefore likely that
AnkH is involved in altering an evolutionarily conserved eukaryotic process required for
the infection by many obligate and facultative intracellular pathogens.
A large number of the Dot/Icm-translocated effector proteins contain eukaryoticlike motifs and domains, which is likely the result of long-term co-evolution of L.
pneumophila with its various protozoan hosts, leading to inter-kingdom horizontal gene
transfer [89, 169-172, 192, 210]. Examples of these eukaryotic domains include F box
and prenylation motifs, U box domain, leucine-rich repeats, and ankyrin repeat domains
(ARDs), which are protein-protein interactions domains [54, 150, 211-213].
The ankyrin repeat (AR) is a structural fold composed of two α-helices forming a
helix-turn-helix motif. It is one of the most commonly structural motifs found in
eukaryotic proteins [54, 169]. AR-containing domains (ARD) usually contain multiple
ARs [181, 214-218] and function predominantly as protein-protein interactions scaffolds
[219, 220]. Many bacterial pathogens that inject protein effectors into host cells harbor
eukaryotic-like ARD-containing protein effectors that interact with specific host targets
[89, 165, 221]. Among 58 sequenced species of Legionella, 1134 ARD-containing

33

effectors have been identified in various combinations with other eukaryotic domains
[137, 138, 187].
While many L. pneumophila effectors are dispensable for intracellular growth of
the pathogen in macrophages, we have previously shown that the AnkH ARD-containing
effector is one of very few effectors required for intracellular replication in macrophages,
amoebae, and for intrapulmonary proliferation in the A/J mouse model [186, 187]. We
have also shown that AnkH is one of the effector proteins that contains an asparagine
hydroxylation motif (Lxxxxx(D/E)(ILVA)N(ILVA)), which is hydroxylated in human
macrophages [179, 186].
While no L. pneumophila effectors have been shown to interfere directly with
host transcription machinery, few L. pneumophila effectors have been identified that
modulate host translation machinery. Five effectors (Lgt1, Lgt2, Lgt3, SidI, and SidL) act
on host translation machinery primarily by interfering with the host elongation factors
eELF1A and eELF1Bγ [145, 146, 222, 223]. In contrast, the RomA (or LegAS4)
effectors are SET-domain containing proteins that directly modify host chromatin
through histone modification but the effect on host transcription is not known [224, 225].
The LegK7 effector interferes with the host Hippo signaling pathway, which results in the
degradation of TAZ and YAP1 transcriptional regulators to alter the transcriptional
profile of mammalian macrophages [226].
No bacterial effector has been shown to modulate the function of 7SK small
nuclear ribonucleoprotein (7SK snRNP). The La related protein 7 (LARP7) is a
component of the 7SK snRNP complex which controls the pausing time of Pol II at the
initiation of transcriptional elongation at almost all metazoan genes [227-229]. Binding of
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LARP7 to the 7SK 3’-terminal U-rich sequence protects 7SK from nucleolytic
degradation [229-233]. The canonical 7SK snRNP core complex consists of 7SK,
LARP7, and γ-methylphosphate capping enzyme (MePCE) [227-229]. Formation of the
7SK snRNP core complex enables recruitment of transcription elongation factor b (PTEFb; Cdk9-cyclin T1 heterodimer) and HEXIM1/2 dimer to the complex [228, 231,
234-237]. Binding and sequestration of P-TEFb within the 7SK snRNP complex results
in inhibition of its kinase activity and continued pause in Pol II transcription elongation
[230, 233, 238, 239]. P-TEFb is the critical factor that controls the release of paused Pol
II into productive elongation at almost all metazoan genes. Various stimuli trigger the
release of P-TEFb from the 7SK snRNP complex, leading to activation of its kinase
activity and transition of Pol II into productive transcriptional elongation [240, 241]. Our
data indicate that the β-hairpin loop of the third ankyrin repeat of AnkH interacts with
LARP7. The AnkH-LARP7 interaction impedes interaction of LARP7 with the 7SK
snRNP complex components, which would trigger transcriptional elongation by Pol II
leading to host global transcriptional reprogramming.

Results
Interaction of AnkH with the LARP7 host protein
We utilized the yeast two-hybrid system to identify potential host cell interacting
partners of AnkH. The full-length coding sequence of AnkH served as the bait construct
and the normalized universal human library was used for the prey. After mating of the
two yeast strains, a total of 1004 potentially positive clones were identified, and their
growth on a selective media narrowed the number of positive clones to 37. After multiple
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rounds of co-transformations of AnkH and the 37 positive clones, seven potential
interacting partners of AnkH were identified (Table 2-1). Of the seven host proteins
candidates, LARP7 was the only positive in all co-transformations and we pursued
verification of its interaction with AnkH.

Table 2-1. Potential interacting partners identified in Y2H screen.
Proteins identified by Yeast 2 Hybrid Assay
LA related protein 7 (LARP7)
Involved in global transcription regulation
Intersectin 2 (INST2)
Adaptor protein involved in trafficking of
endocytic vesicles
Ubiquitin specific peptidase like 1
SUMO specific isopeptidase involved in
(USPL1)
protein desumoylation
ANK repeat domain 18A (ANKRD18A)
Possible role in global regulation of platelet
function and number
TOX4
Involved in regulating chromatin structure
and cell cycle progression
Sodium channel modifier 1 (SNCM1)
Zinc finger protein and putative splicing
factor
HLA-DQA1
Involved in process of presenting antigens
on cell surface

The LARP7 protein is a component of the 7SK snRNP complex, which enables
continued pause of Pol II elongation through sequestering and inhibiting the kinase
activity of P-TEFb [242]. To confirm the AnkH-LARP7 interaction, tagged-AnkH and
LARP7 were co-transfected into human embryonic kidney (HEK293T) cells and
subjected to reciprocal co-immunoprecipitation (co-IP) by IP of AnkH or LARP7 (Fig. 21A). The data showed that LARP7 was pulled down with AnkH in the reciprocal co-IPs
(Fig. 2-1A, third lane from left). To determine if AnkH-LARP7 interaction impacted
recruitment of critical components essential for sequestration of P-TEFb in the 7SK
snRNP complex, we determined whether the LARP7-AnkH complex interacted with the
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7SK snRNP components. The AnkH co-IP was probed in immunoblots for components
of the 7SK snRNP complex (CDK9, CyclinT1, MePCE, HEXIM 1/2). The data showed
that none of the other complex components were immunoprecipitated with the LARP7AnkH complex, similar to the vector control (Fig. 2-1B). However, MePCE was
immunoprecipitated with the LARP7-AnkH complex 60% of the time (3 out of 5
replicates). This could be the result of expression of MePCE and the transient formation
of the 7SK snRNP complex or that these MePCE positive samples were
immunoprecipitated in instances where LARP7 is part of the complex and has not yet
been removed from the complex via the LARP7-AnkH interaction. Importantly, in the
absence of AnkH, all the 7SK snRNP components immunoprecipitated in a complex with
LARP7 (Fig. 2-1C). Our data show that AnkH specifically interacts in vivo with the
LARP7 protein and this impedes interaction of LARP7 with critical components of the
7SK snRNP complex required for the sequestration of P-TEFb in the 7SK snRNP
complex.
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Figure 2-1. Interaction of LARP7 with the AnkH effector. (A) HEK293T cells were
transiently transfected with 3xFLAG-AnkH or 3xFLAG-BAP and c-myc-LARP7, and
immuneprecipitated with anti-FLAG or anti-myc antibody, and the co-IP was
immunoblotted to detect the presence of AnkH and LARP7. (B) The AnkH co-IP was
immunoblotted against 7SK snRNP complex components. (C) HEK293T cells were
transiently transfected with c-myc-LARP7 and immunoprecipitated with anti-myc
antibody and the IP was immunoblotted to detect the presence of 7SK snRNP complex
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components. Lanes for total cell lysates of the immunoblot were imaged for less time due
to high intensity signal. Results are representative of five independent experiments.

Localization of AnkH with LARP7 to the host cell nucleus
Consistent with its role in transcription, LARP7 is localized primarily in the
nucleus [242]. Since AnkH interacts with LARP7, we determined whether the AnkH
effector was targeted to the nucleus. HEK293T cells were transfected with a plasmid
containing tagged AnkH and subcellular localization of AnkH was examined using
confocal microscopy (Fig. 2-2A). In 85% of transfected cells, the AnkH effector was
predominantly localized to the nucleus in addition to some cytosolic localization (Fig. 22A). In contrast, the AnkB effector control was primarily localized to the plasma
membrane (92%) (Fig. 2-2A) [177].
To confirm sub-cellular localization of AnkH, nuclear and cytoplasmic fractions were
analyzed by immunoblotting. In cells transfected with tagged AnkH, the majority of
AnkH was present in both the nuclear and cytoplasmic fractions (Fig. 2-2B), while the
AnkB effector control was mainly localized to the cytoplasmic fraction (Fig. 2-2B).
Cellular fractionation was confirmed using the nuclear protein Lamin as a control (Fig. 22B).
To determine if AnkH and LARP7 were simultaneously localized to the nucleus,
HEK293T cells were transfected with tagged AnkH and LARP7 and confocal
microscopy was performed. The tagged bacterial alkaline phosphatase (BAP) was used as
the control. Our data confirmed that ~70% of the cells showed simultaneous localization
of AnkH and LARP7 in the nucleus (Student t-test p < 0.01) (Fig 2-2C), compared to the
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Figure 2-2. Localization of AnkH with LARP7 in the nucleus. (A) Representative
confocal microscopy images of HEK293T cells transiently transfected with 3xFLAGAnkH or 3xFLAG-AnkB control. The cells were labeled with anti-FLAG antibody
(green), and the nucleus is stained with DAPI (blue). (B) Representative confocal
microscopy images of HEK293T cells transiently co-transfected with 3xFLAG-AnkH
and c-myc-LARP7 or 3xFLAG-BAP and c-myc-LARP7. The cells were labeled with
anti-FLAG (green), anti-myc (red), and the nucleus is stained with DAPI (blue). Numbers
in the merged images in (A) and (B) are quantification of % of nuclear localizations of
AnkH and LARP7 proteins in HEK293T cells. For (A) and (B), 100 transfected cells
were analyzed from multiple coverslips. Results are representative of three independent
experiments performed in triplicate. (C) HEK293T cells transiently transfected with
3xFLAG-AnkH or 3xFLAG-AnkB control were subjected to nuclear fractionation. Cell
fractions were separated by SDS-PAGE and analyzed by immunoblotting. AnkH and
AnkB were detected using anti-FLAG monoclonal antibody. Fractionation was confirmed
by detection of the nuclear protein Lamin.
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control BAP (~30%), which is a highly expressed protein (Fig. 2-2C). Our data showed
that AnkH and LARP7 are localized to the nucleus, consistent with their interaction.
Role of LARP7 in intracellular replication of L. pneumophila in hMDMs
We have previously shown that AnkH is required for intracellular replication of L.
pneumophila in macrophage and amoeba [186, 187]. Depletion of either LARP7 or
MePCE via RNAi triggers 7SK degradation in cells [231, 235, 243]. Since AnkH
interacts with the LARP7 component of the 7SK snRNP complex, we investigated if
LARP7 was also required for replication of L. pneumophila. We utilized a lentiviral
RNAi system to knockdown expression of LARP7 in human monocyte derived
macrophages (hMDMs) that were infected with the WT strain of L. pneumophila or the
∆ankH null mutant. Knockdown of LARP7 was confirmed by immunoblot (Fig. 2-3A).
Interestingly, when LARP7 was knocked down and cells were infected with the ΔankH,
the defective phenotype was exacerbated. Surprisingly, the knockdown of LARP7
resulted in a partial but significant decrease in intracellular replication of the WT strain
(Student t-test p < 0.05), which was not observed in non-treated or control RNAi-treated
cells (Fig. 2-3B). These data support our findings for the role of AnkH-LARP7
interaction in intracellular replication of L. pneumophila in hMDMs and indicates that
LARP7 is involved in transcription of genes involved in permissiveness to L.
pneumophila.
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Figure 2-3. Requirement of LARP7 for intracellular replication of L. pneumophila.
(A) Cells were treated with LARP7 RNAi for 24 hours then infected. Knockdown of
LARP7 was determined by immunoblotting with anti-LARP7 polyclonal antibody. (B)
Intracellular growth kinetics of L. pneumophila in hMDMs treated with LARP7-specific
or scrambled RNAi. The results are representative of three independent experiments
performed in triplicate. Statistical analysis was performed comparing all conditions to
WT untreated using Student’s T test where *, P < 0.05.
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Alteration of host global transcription by AnkH
Our data showed that the LARP7-AnkH complex impedes interaction of LARP7
with critical components of the 7SK snRNP complex required for the sequestration of PTEFb in the 7SK snRNP complex, which indicates an active P-TEFb kinase and release
of Pol II from pause sites and transitions into productive transcriptional elongation [231,
242]. We utilized RNAseq to examine modulation of global gene expression in hMDMs
infected with either the WT strain or the ∆ankH null mutant. The data showed deletion of
AnkH had a dramatic effect on global transcription of L. pneumophila-infected hMDMs,
with a total of 405 genes that were differentially regulated in cells infected with the WT
strain compared to the ∆ankH mutant, the top 10 of each based on log-fold change are
listed in Table 2-2 (Full list in Table 2-3 & 2-4). MetaCore was used to determine which
pathways were differentially regulated based on p values. Certain cellular pathways were
downregulated in AnkH-dependent manner, including apoptosis, autophagy and certain
signaling pathways including STK3/4 pathway and JNK pathway, indicating negative
regulation of these pathways by AnkH during infection (Table 2-5). When cells were
infected with the ∆ankH null mutant, transcription and immune response pathways were
downregulated compared to cells infected with the WT strain, indicating their
upregulation by AnkH (Table 2-5). An array of 10 cytokines were tested based on
RNAseq data to determine which were altered by the presence of AnkH (Figure 2-4A-H).
Human monocyte derived macrophages were infected with WT or ∆ankH L.
pneumophila for 6 hours. Supernatants were collected and centrifuged to remove debris
then cytokine levels were tested using a 10-panel cytokine multiplex. Of the 10 cytokines
tested, only eight produced levels that were in a detectable range, and only IL-1α, showed
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a significant difference in cells infected with WT versus ∆ankH (Figure 2-4G). These
data show that AnkH triggers a dramatic reprogramming of cellular transcription and that
is most likely mediated by interaction with several host substrates, one of which is
LARP7.

Table 2-2: Top 10 up regulated and top 10 down regulated genes in cells infected
with ankH mutant compared to cells infected with WT.
Gene Symbol | Description
Log2FC Gene Symbol | Description
Log2FC
HSPA1B| Heat shock 70kDa protein
+2.9979
TMC8|Transmembrane
-2.75204
1B
channel-like 8
EGR1| Early growth response 1 +2.25815 HMHA1| Histocompatibility -1.99385
(minor) HA-1
DNAJB1| DnaJ (Hsp40)
+1.51215
DAPK3|Death associated
-1.91505
homolog, subunit B, member 1
protein kinase 3
DUSP1| Dual specificity
+1.24951
PDLIM2|PDZ and LIM
-1.79007
phosphatase 1
domain 2
FOS| FBJ murine osteosarcoma +1.15258
SDF2L1|Stromal cell-1.65596
viral oncogene homolog
derived factor 2-like 1
TDO2| Tryptophan metabolism +1.01074
TOR2A|Torsin family 2,
-1.62058
member A
MS4A4E| Membrane-spanning +2.36464
LMF2|Lipase maturation
-1.59493
4-domains, subfamily A,
factor 2
member 4E
PKIB| Protein kinase inhibitor
+1.33129
NOTCH3| Notch 3
-1.57732
beta
PEG3| Paternally espressed 3
+2.64637
IL27| Interleukin 27
-1.55472
GRIK2| Glutamate receptor,
+1.78851
CPSF1|Cleavage and
-1.89935
ionotropic, kainate 2
polyadenylation specific
factor 1
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Table 2-3: Complete list of genes upregulated in hMDMs infected with ΔankH null
mutant compared to WT strain of L. pneumophila.
ENSEMBL GENE

ENTREZ ID

ENSG00000120129

1843

ENSG00000120738

1958

ENSG00000132002

3337

ENSG00000135549

5570

ENSG00000151790

6999

ENSG00000152380

167555

ENSG00000164418

2898

ENSG00000165694

90167

ENSG00000170345

2353

ENSG00000185842

127602

ENSG00000198300

5178

ENSG00000204388

3304

ENSG00000214787

643680

ENSG00000225465

GENE
SYMBOL|DESCRIPTION
DUSP1|dual specificity
phosphatase 1
EGR1|early growth response
1
DNAJB1|DnaJ (Hsp40)
homolog, subfamily B,
member 1
PKIB|protein kinase (cAMPdependent, catalytic)
inhibitor beta
TDO2|tryptophan 2,3dioxygenase
FAM151B|family with
sequence similarity 151,
member B
GRIK2|glutamate receptor,
ionotropic, kainate 2
FRMD7|FERM domain
containing 7
FOS|FBJ murine
osteosarcoma viral
oncogene homolog
DNAH14|dynein, axonemal,
heavy chain 14
PEG3|paternally expressed 3

log2FC
(ankh/wild_type)
1.24951

p_value

2.25815

5.00E-05

1.51215

5.00E-05

1.33129

0.00105

1.01074

0.0006

1.08992

0.00015

1.78851

0.00245

1.3049

5.00E-05

1.15258

5.00E-05

1.00125

0.0014

2.64637

0.0013

HSPA1B|heat shock 70kDa
protein 1B
MS4A4E|membranespanning 4-domains,
subfamily A, member 4E
RFPL1S|

2.9979

5.00E-05

2.36464

0.001

2.61193

0.00195

1.04367

0.0009

2.66729

5.00E-05

1.22918

0.00125

1.10281

5.00E-05

1.01595

0.00595

1.32999

5.00E-05

1.02381

5.00E-05

ENSG00000226047
ENSG00000227028

100128590

ENSG00000229956

100852410

ENSG00000234506

101927015

ENSG00000245573

497258

ENSG00000262097

101927311

SLC8A1-AS1|SLC8A1
antisense RNA 1
ZRANB2-AS2|ZRANB2
antisense RNA 2 (head to
head)
LINC01506|long intergenic
non-protein coding RNA
1506
BDNF-AS|BDNF antisense
RNA
|uncharacterized
LOC101927311

ENSG00000279348
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5.00E-05

Table 2-4: Complete list of genes downregulated in hMDMs infected with ΔankH
null mutant compared to WT strain of L. pneumophila.
ENSEMBL GENE

ENTREZ ID

GENE SYMBOL|DESCRIPTION

ENSG000000050
75
ENSG000000083
82
ENSG000000084
41
ENSG000000102
95
ENSG000000110
28
ENSG000000141
64
ENSG000000152
85
ENSG000000217
62
ENSG000000231
91
ENSG000000257
70
ENSG000000295
34
ENSG000000305
82
ENSG000000370
42
ENSG000000508
20
ENSG000000511
28
ENSG000000515
23
ENSG000000619
38
ENSG000000632
45
ENSG000000638
54
ENSG000000644
90

5439

POLR2J|polymerase (RNA) II (DNA
directed) polypeptide J, 13.3kDa
MPND|MPN domain containing

ENSG000000646
87
ENSG000000652
68
ENSG000000653

10347

84954
4784

log2FC
(ankh/wild_type
)
-1.00719

p_value

-1.13737

0.0030
5
0.0021
5
5.00E05
0.0001

NFIX|nuclear factor I/X (CCAATbinding transcription factor)
IFFO1|intermediate filament
family orphan 1
MRC2|mannose receptor, C type 2

-1.56187

ZC3H3|zinc finger CCCH-type
containing 3
WAS|Wiskott-Aldrich syndrome

-1.16549

-1.0211

286

OSBPL5|oxysterol binding proteinlike 5
RNH1|ribonuclease/angiogenin
inhibitor 1
NCAPH2|non-SMC condensin II
complex, subunit H2
ANK1|ankyrin 1, erythrocytic

2896

GRN|granulin

-1.10623

27175

TUBG2|tubulin, gamma 2

-1.06627

9564

BCAR1|breast cancer antiestrogen resistance 1
HOMER3|homer scaffolding
protein 3
CYBA|cytochrome b-245, alpha
polypeptide
TNK2|tyrosine kinase, nonreceptor, 2
EPN1|epsin 1

-1.06863

-1.02578

57418

HAGH|hydroxyacylglutathione
hydrolase
RFXANK|regulatory factor Xassociated ankyrin-containing
protein
ABCA7|ATP-binding cassette, subfamily A (ABC1), member 7
WDR18|WD repeat domain 18

9423

NTN1|netrin 1

25900
9902
23144
7454
114879
6050
29781

9454
1535
10188
29924
3029
8625
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-1.02159
-1.58459

-1.02431

-1.21807
-1.01792
-1.56839

-1.92266
-1.24454
-1.22665
-1.40878

0.0004

5.00E05
5.00E05
0.0032
5
5.00E05
0.0008
5
0.0002
5
5.00E05
0.001
0.0047
5
0.0026
5.00E05
0.0003
5
5.00E05
0.003

-1.10454

0.0011
5

-1.16013
-1.24648

0.0030
5
0.0052

-1.27328

0.0001

20

5

ENSG000000680
01
ENSG000000704
04
ENSG000000704
13
ENSG000000718
59
ENSG000000718
89
ENSG000000718
94

8692

-1.02605

0.0037

-1.47082

0.0003
5
0.0010
5
0.0007

87

HYAL2|hyaluronoglucosaminidase
2
FSTL3|follistatin-like 3 (secreted
glycoprotein)
DGCR2|DiGeorge syndrome
critical region gene 2
FAM50A|family with sequence
similarity 50, member A
FAM3A|family with sequence
similarity 3, member A
CPSF1|cleavage and
polyadenylation specific factor 1,
160kDa
ACTN1|actinin, alpha 1

ENSG000000721
10
ENSG000000727
86
ENSG000000741
81
ENSG000000749
64

6793

STK10|serine/threonine kinase 10

-1.09231

4854

NOTCH3|notch 3

-1.57732

55160

ARHGEF10L|Rho guanine
nucleotide exchange factor (GEF)
10-like
FSCN1|fascin actin-bundling
protein 1
XAB2|XPA binding protein 2

-1.11483

ENSG000000756
18
ENSG000000769
24
ENSG000000774
54

6624

-1.18425

8871

LRCH4|leucine-rich repeats and
calponin homology (CH) domain
containing 4
SYNJ2|synaptojanin 2

ENSG000000782
69
ENSG000000788
08
ENSG000000794
32
ENSG000000805
73
ENSG000000838
38
ENSG000000851
17
ENSG000000882
56

51150

SDF4|stromal cell derived factor 4

-1.34504

23152

-1.26161

50509

CIC|capicua transcriptional
repressor
COL5A3|collagen, type V, alpha 3

55663

ZNF446|zinc finger protein 446

-1.70362

3732

CD82|CD82 molecule

-1.09771

2767

GNA11|guanine nucleotide
binding protein (G protein), alpha
11 (Gq class)
BLVRB|biliverdin reductase B

-1.47458

ENSG000000900
13
ENSG000000953
97
ENSG000000998
17

645

DFNB31|deafness, autosomal
recessive 31
POLR2E|polymerase (RNA) II (DNA
directed) polypeptide E, 25kDa

-1.94109

10272
9993
9130
60343
29894

56949
4034

25861
5434
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-1.08748
-1.03637
-1.10308
-1.89935

-1.02917

-1.54859
-1.45048

-1.03271

-1.26729

-1.05725

-1.17485

5.00E05
5.00E05
5.00E05
5.00E05
5.00E05
0.0009
5
5.00E05
5.00E05
5.00E05
0.0051
5
5.00E05
0.0007
5.00E05
0.0043
5
5.00E05
5.00E05
5.00E05
0.0003
5
0.0013
5

ENSG000000998
21
ENSG000000999
95
ENSG000001000
56
ENSG000001000
75

5442

-1.29291

6305

POLRMT|polymerase (RNA)
mitochondrial (DNA directed)
SF3A1|splicing factor 3a, subunit
1, 120kDa
DGCR14|DiGeorge syndrome
critical region gene 14
SLC25A1|solute carrier family 25
(mitochondrial carrier; citrate
transporter), member 1
LGALS1|lectin, galactosidebinding, soluble, 1
CCDC134|coiled-coil domain
containing 134
SBF1|SET binding factor 1

ENSG000001000
97
ENSG000001001
47
ENSG000001002
41
ENSG000001002
58
ENSG000001002
92
ENSG000001002
99
ENSG000001003
00
ENSG000001003
19
ENSG000001004
17
ENSG000001004
25
ENSG000001004
29
ENSG000001009
49

3956

91289

LMF2|lipase maturation factor 2

-1.59493

3162

HMOX1|heme oxygenase 1

-1.08059

410

ARSA|arylsulfatase A

-1.05355

706

TSPO|translocator protein (18kDa)

-1.12915

55954

ZMAT5|zinc finger, matrin-type 5

-1.14104

5372

PMM1|phosphomannomutase 1

-1.44872

23774

BRD1|bromodomain containing 1

-1.0918

83933

HDAC10|histone deacetylase 10

-1.30876

5875

RABGGTA|Rab
geranylgeranyltransferase, alpha
subunit
MMP9|matrix metallopeptidase 9

-1.06608

ENSG000001009
85
ENSG000001011
94

4318

SLC17A9|solute carrier family 17
(vesicular nucleotide transporter),
member 9
MYL9|myosin, light chain 9,
regulatory
WFDC2|WAP four-disulfide core
domain 2
ABCD1|ATP-binding cassette, subfamily D (ALD), member 1
CCDC22|coiled-coil domain
containing 22
TIMP1|TIMP metallopeptidase
inhibitor 1
CORO1A|coronin, actin binding
protein, 1A

-1.14327

ENSG000001013
35
ENSG000001014
43
ENSG000001019
86
ENSG000001019
97
ENSG000001022
65
ENSG000001028
79

10398

10291
8220
6576

79879

63910

10406
215
28952
7076
11151
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-1.15539
-1.05868
-1.07913

-1.05694
-1.1867
-1.6413

-1.06531

-1.0549
-1.6624
-1.45046
-1.08562
-1.0606
-1.06787

0.0033
5
0.0006
0.0004
5
5.00E05
5.00E05
0.0001
5
0.0001
5
5.00E05
5.00E05
0.0006
5.00E05
5.00E05
5.00E05
0.0017
5.00E05
5.00E05
5.00E05
5.00E05
0.0022
5
0.0038
5.00E05
5.00E05
5.00E05
5.00E05

ENSG000001031
45
ENSG000001032
57

54985

HCFC1R1|host cell factor C1
regulator 1 (XPO1 dependent)
SLC7A5|solute carrier family 7
(amino acid transporter light
chain, L system), member 5
PIEZO1|piezo-type
mechanosensitive ion channel
component 1
CSK|c-src tyrosine kinase

-1.00296

ENSG000001033
35

9780

ENSG000001036
53
ENSG000001043
68
ENSG000001049
07
ENSG000001049
73
ENSG000001049
76

1445

PLAT|plasminogen activator,
tissue
TRMT1|tRNA methyltransferase 1

-1.51427

MED25|mediator complex subunit
25
SNAPC2|small nuclear RNA
activating complex, polypeptide 2,
45kDa
DYRK1B|dual-specificity tyrosine(Y)-phosphorylation regulated
kinase 1B
PLD3|phospholipase D family,
member 3
PIAS4|protein inhibitor of
activated STAT, 4
NKG7|natural killer cell granule
protein 7
COPE|coatomer protein complex,
subunit epsilon
FKBP8|FK506 binding protein 8,
38kDa
PBX4|pre-B-cell leukemia
homeobox 4
GSK3A|glycogen synthase kinase 3
alpha
ZNF574|zinc finger protein 574

-1.51656

ENSG000001052
04

9149

ENSG000001052
23
ENSG000001052
29
ENSG000001053
74
ENSG000001056
69
ENSG000001057
01
ENSG000001057
17
ENSG000001057
23
ENSG000001057
32
ENSG000001060
09
ENSG000001063
48
ENSG000001066
83
ENSG000001078
16
ENSG000001086
39
ENSG000001088
40
ENSG000001097
36

23646

BRAT1|BRCA1-associated ATM
activator 1
IMPDH1|IMP (inosine 5'monophosphate) dehydrogenase 1
LIMK1|LIM domain kinase 1

-1.35966

-1.12868

9144

LZTS2|leucine zipper, putative
tumor suppressor 2
SYNGR2|synaptogyrin 2

10014

HDAC5|histone deacetylase 5

-1.07427

10227

MFSD10|major facilitator
superfamily domain containing 10

-1.23104

8140

5327
55621
81857
6618

51588
4818
11316
23770
80714
2931
64763
221927
3614
3984
84445
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-1.07431

0.0002
5
5.00E05

-1.04014

0.003

-1.20218

5.00E05
5.00E05
0.0011
5
0.0024

-1.04471

-1.68231

0.0001
5

-1.28731

0.0018

-1.04403

5.00E05
0.0012
5
5.00E05
0.0003
5
5.00E05
0.0019

-1.88599
-1.11691
-1.00067
-1.50269
-1.63027
-1.21067
-1.53883

-1.2246
-1.28683

-1.0749

5.00E05
0.0001
5
0.0044
5
5.00E05
5.00E05
0.0010
5
5.00E05
0.0002
5
5.00E05

ENSG000001100
25
ENSG000001100
46
ENSG000001104
46

29907

SNX15|sorting nexin 15

-5.02403

0.0016

23130

ATG2A|autophagy related 2A

-1.21033

0.0002

51296

-1.04048

5.00E05

ENSG000001107
17

4728

-1.04348

5.00E05

ENSG000001109
44
ENSG000001113
21
ENSG000001116
78
ENSG000001134
94
ENSG000001136
57
ENSG000001145
54
ENSG000001146
26
ENSG000001150
85
ENSG000001152
86

51561

SLC15A3|solute carrier family 15
(oligopeptide transporter),
member 3
NDUFS8|NADH dehydrogenase
(ubiquinone) Fe-S protein 8, 23kDa
(NADH-coenzyme Q reductase)
IL23A|interleukin 23, alpha
subunit p19
LTBR|lymphotoxin beta receptor
(TNFR superfamily, member 3)
C12orf57|chromosome 12 open
reading frame 57
PRLR|prolactin receptor

-1.04283

5.00E05
5.00E05
0.0036

DPYSL3|dihydropyrimidinase-like
3
PLXNA1|plexin A1

-1.12821

-1.08265

ENSG000001157
18
ENSG000001166
91
ENSG000001168
09
ENSG000001179
84
ENSG000001208
99
ENSG000001209
13
ENSG000001209
49
ENSG000001210
57
ENSG000001231
43
ENSG000001234
53
ENSG000001242
16

5624

ABTB1|ankyrin repeat and BTB
(POZ) domain containing 1
ZAP70|zeta-chain (TCR) associated
protein kinase 70kDa
NDUFS7|NADH dehydrogenase
(ubiquinone) Fe-S protein 7, 20kDa
(NADH-coenzyme Q reductase)
PROC|protein C (inactivator of
coagulation factors Va and VIIIa)
MIIP|migration and invasion
inhibitory protein
ZBTB17|zinc finger and BTB
domain containing 17
CTSD|cathepsin D

-1.15075

5585

PTK2B|protein tyrosine kinase 2
beta
PDLIM2|PDZ and LIM domain 2
(mystique)
TNFRSF8|tumor necrosis factor
receptor superfamily, member 8
AKAP1|A kinase (PRKA) anchor
protein 1
PKN1|protein kinase N1

1757

SARDH|sarcosine dehydrogenase

-1.14408

6615

SNAI1|snail family zinc finger 1

-1.78349

4055
113246
5618
1809
5361
80325
7535
374291

60672
7709
1509
2185
64236
943
8165

50

-1.05988
-1.18795
-1.28143

-1.40661

-2.2362
-1.2702

0.0021
5
5.00E05
0.0026
5
0.0018
0.0002
5
0.0028
5

-1.5442

0.0027

-1.06346

5.00E05
5.00E05
5.00E05
5.00E05
5.00E05
5.00E05
0.0005
5
5.00E05
0.0002

-1.2056
-1.18663

-1.7752
-1.03051
-1.03472
-1.00546

0.0019
5

ENSG000001250
89
ENSG000001251
48
ENSG000001255
03
ENSG000001255
34

54436

SH3TC1|SH3 domain and
tetratricopeptide repeats 1
MT2A|metallothionein 2A

-1.0519

PPP1R12C|protein phosphatase 1,
regulatory subunit 12C
PPDPF|pancreatic progenitor cell
differentiation and proliferation
factor
CLPP|caseinolytic mitochondrial
matrix peptidase proteolytic
subunit
CD70|CD70 molecule

-1.29062

ENSG000001256
56

8192

ENSG000001257
26
ENSG000001258
17
ENSG000001259
12
ENSG000001260
62
ENSG000001262
54
ENSG000001263
53
ENSG000001264
61
ENSG000001265
61
ENSG000001269
03
ENSG000001269
34
ENSG000001276
63
ENSG000001276
66
ENSG000001282
28
ENSG000001282
71
ENSG000001283
42
ENSG000001299
11
ENSG000001299
25
ENSG000001301
65
ENSG000001302
03
ENSG000001302
22

970

CENPB|centromere protein B,
80kDa
NCLN|nicalin

-1.06327

-1.19645

3976

TMEM115|transmembrane
protein 115
RBM42|RNA binding motif protein
42
CCR7|chemokine (C-C motif)
receptor 7
SCAF1|SR-related CTD-associated
factor 1
STAT5A|signal transducer and
activator of transcription 5A
SLC10A3|solute carrier family 10,
member 3
MAP2K2|mitogen-activated
protein kinase kinase 2
KDM4B|lysine (K)-specific
demethylase 4B
TICAM1|toll-like receptor adaptor
molecule 1
SDF2L1|stromal cell-derived factor
2-like 1
ADORA2A|adenosine A2a
receptor
LIF|leukemia inhibitory factor

83855

KLF16|Kruppel-like factor 16

-1.04128

58986

TMEM8A|transmembrane protein
8A
ELOF1|ELF1 homolog, elongation
factor 1
APOE|apolipoprotein E

-1.35995

GADD45G|growth arrest and DNAdamage-inducible, gamma

-1.11982

4502
54776
79144

1059
56926
11070
79171
1236
58506
6776
8273
5605
23030
148022
23753
135

84337
348
10912

51

-1.06199

-1.42636

0.0001
5
5.00E05
5.00E05
5.00E05

-1.14732

5.00E05

-1.07511

0.0003
5
5.00E05
5.00E05
5.00E05
5.00E05
5.00E05
5.00E05
5.00E05
5.00E05
5.00E05
5.00E05
5.00E05
5.00E05
0.0041
5
5.00E05
5.00E05
5.00E05
5.00E05
5.00E05
0.0008

-1.60475

-1.67206
-1.03117
-1.67049
-1.08881
-1.01445
-1.03897
-1.5128
-1.0486
-1.65596
-1.51909
-1.17852

-1.04415
-1.35627

ENSG000001302
55
ENSG000001303
13
ENSG000001304
79
ENSG000001307
06
ENSG000001307
26
ENSG000001311
65
ENSG000001314
59
ENSG000001316
53
ENSG000001316
69
ENSG000001317
59
ENSG000001320
17
ENSG000001323
82
ENSG000001330
27
ENSG000001330
69
ENSG000001332
75
ENSG000001350
94
ENSG000001357
23
ENSG000001362
86
ENSG000001367
17
ENSG000001368
77
ENSG000001371
66
ENSG000001372
21
ENSG000001372
66
ENSG000001378
18
ENSG000001380
80
ENSG000001395

25873

RPL36|ribosomal protein L36

-1.11055

0.0001

25796

PGLS|6-phosphogluconolactonase

-1.22736

55201

-1.1206

4814

MAP1S|microtubule-associated
protein 1S
ADRM1|adhesion regulating
molecule 1
TRIM28|tripartite motif containing
28
CHMP1A|charged multivesicular
body protein 1A
GFPT2|glutamine-fructose-6phosphate transaminase 2
TRAF7|TNF receptor-associated
factor 7, E3 ubiquitin protein ligase
NINJ1|ninjurin 1

5914

RARA|retinoic acid receptor, alpha

-1.14887

90379

DCAF15|DDB1 and CUL4
associated factor 15
MYBBP1A|MYB binding protein
(P160) 1a
PEMT|phosphatidylethanolamine
N-methyltransferase
TMCC2|transmembrane and
coiled-coil domain family 2
CSNK1G2|casein kinase 1, gamma
2
SDS|serine dehydratase

-1.20722

5.00E05
5.00E05
5.00E05
5.00E05
5.00E05
5.00E05
0.0001
5
5.00E05
5.00E05
0.0003
5
0.0008

-1.22406

64005

FHOD1|formin homology 2
domain containing 1
MYO1G|myosin IG

274

BIN1|bridging integrator 1

-1.00875

2356

FPGS|folylpolyglutamate synthase

-1.20062

116113

FOXP4|forkhead box P4

-1.45906

93643

TJAP1|tight junction associated
protein 1 (peripheral)
SLC22A23|solute carrier family 22,
member 23
RPLP1|ribosomal protein, large, P1

-1.18844

EMILIN1|elastin microfibril
interfacer 1
ACVRL1|activin A receptor type II-

-1.52419

11047
10155
5119
9945
84231

10514
10400
9911
1455
10993
29109

63027
6176
11117
94

52

-1.1761
-1.0238
-1.09835
-1.10419
-1.41604
-1.35514

-1.00679
-1.50047
-1.31481
-1.29917
-1.05989

-1.06235

-1.00819
-1.18368

-1.09297

5.00E05
5.00E05
0.0047
5
5.00E05
0.0009
5
5.00E05
5.00E05
5.00E05
0.0004
0.0006
5
0.0050
5
5.00E05
5.00E05
0.0025

67

like 1

ENSG000001405
48
ENSG000001408
54
ENSG000001409
39

374655

ZNF710|zinc finger protein 710

-1.03225

0.0063

10300

-1.00905

0.0025

-1.33415

0.0001

ENSG000001415
26

9123

-1.11006

0.0005
5

ENSG000001419
85
ENSG000001419
94
ENSG000001421
86
ENSG000001425
46
ENSG000001433
73
ENSG000001437
74
ENSG000001444
76
ENSG000001445
79

6455

KATNB1|katanin p80 (WD repeat
containing) subunit B 1
NOL3|nucleolar protein 3
(apoptosis repressor with CARD
domain)
SLC16A3|solute carrier family 16
(monocarboxylate transporter),
member 3
SH3GL1|SH3-domain GRB2-like 1

-1.01881

DUS3L|dihydrouridine synthase 3like
SCYL1|SCY1-like, kinase-like 1

-1.48655

-1.00975

57592

NOSIP|nitric oxide synthase
interacting protein
ZNF687|zinc finger protein 687

5.00E05
0.0008
5
5.00E05
5.00E05
0.0059

2987

GUK1|guanylate kinase 1

-1.12173

57007

-1.37842

ENSG000001459
01
ENSG000001459
36

10318

ENSG000001474
43
ENSG000001483
43
ENSG000001497
81
ENSG000001497
82
ENSG000001499
25
ENSG000001506
72
ENSG000001516
51
ENSG000001534
43
ENSG000001540

9046

ACKR3|atypical chemokine
receptor 3
CTDSP1|CTD (carboxy-terminal
domain, RNA polymerase II,
polypeptide A) small phosphatase
1
TNIP1|TNFAIP3 interacting protein
1
KCNMB1|potassium channel
subfamily M regulatory beta
subunit 1
DOK2|docking protein 2, 56kDa
FAM73B|family with sequence
similarity 73, member B
FERMT3|fermitin family member 3

-1.53125

PLCB3|phospholipase C, beta 3
(phosphatidylinositol-specific)
ALDOA|aldolase A, fructosebisphosphate
DLG2|discs, large homolog 2
(Drosophila)
ADAM8|ADAM metallopeptidase
domain 8
UBALD1|UBA-like domain
containing 1
DNAAF1|dynein, axonemal,

-1.09659

8996

56931
57410
51070

58190

3779

84895
83706
5331
226
1740
101
124402
123872

53

-1.14476

-1.07338

5.00E05
0.0023

-1.14305

5.00E05

-1.22933

5.00E05
5.00E05

-1.08752

-1.19973

-1.03321

-1.32281
-1.14705
-1.08517
-2.02675
-1.18584

5.00E05
0.0006
5.00E05
5.00E05
5.00E05
0.0054
5.00E05
0.0038
5
0.0001

99

assembly factor 1

ENSG000001569
66

93010

-1.07511

0.0001
5

197258

B3GNT7|UDP-GlcNAc:betaGal
beta-1,3-Nacetylglucosaminyltransferase 7
FUK|fucokinase

ENSG000001573
53
ENSG000001585
17
ENSG000001589
41
ENSG000001590
69
ENSG000001591
66
ENSG000001591
89
ENSG000001593
14
ENSG000001593
63
ENSG000001594
96
ENSG000001602
11
ENSG000001602
85
ENSG000001603
26

-1.20746

653361

NCF1|neutrophil cytosolic factor 1

-1.18042

57805

CCAR2|cell cycle and apoptosis
regulator 2
FBXW5|F-box and WD repeat
domain containing 5
LAD1|ladinin 1

-1.03328

5.00E05
5.00E05
0.0002

-1.37742

0.0044

-1.50991

C1QC|complement component 1,
q subcomponent, C chain
ARHGAP27|Rho GTPase activating
protein 27
ATP13A2|ATPase type 13A2

-1.17726

0.0036
5
5.00E05
0.0017

RGL4|ral guanine nucleotide
dissociation stimulator-like 4
G6PD|glucose-6-phosphate
dehydrogenase
LSS|lanosterol synthase (2,3oxidosqualene-lanosterol cyclase)
SLC2A6|solute carrier family 2
(facilitated glucose transporter),
member 6
TOR2A|torsin family 2, member A

-2.44684

ENSG000001604
04
ENSG000001604
46
ENSG000001607
03
ENSG000001607
89
ENSG000001608
77

27433

-1.41004

79671

ZDHHC12|zinc finger, DHHC-type
containing 12
NLRX1|NLR family member X1

4000

LMNA|lamin A/C

-1.37469

112939

-1.09164

8878

NACC1|nucleus accumbens
associated 1, BEN and BTB (POZ)
domain containing
SQSTM1|sequestosome 1

ENSG000001610
11
ENSG000001610
16
ENSG000001616
53
ENSG000001621
04
ENSG000001623
02
ENSG000001627

6132

RPL8|ribosomal protein L8

-1.01671

162417

NAGS|N-acetylglutamate synthase

-1.02547

115

ADCY9|adenylate cyclase 9

-1.14224

5.00E05
5.00E05
0.0044
5
0.0039

8986

RPS6KA4|ribosomal protein S6
kinase, 90kDa, polypeptide 4
IGSF8|immunoglobulin

-1.01178

0.0002

-1.28496

5.00E-

54461
3898
714
201176
23400
266747
2539
4047
11182

84885

93185

54

-1.75118
-1.22485

-1.21866
-1.12374
-1.12955

-1.62058

-1.04198

-1.15104

0.0003
5
0.0002
5
5.00E05
5.00E05
5.00E05
5.00E05
5.00E05
0.0013
5.00E05
5.00E05

29

superfamily, member 8

ENSG000001628
97
ENSG000001634
30
ENSG000001637
02
ENSG000001638
70
ENSG000001639
31
ENSG000001648
96
ENSG000001648
97
ENSG000001651
78
ENSG000001652
33
ENSG000001658
86
ENSG000001661
33
ENSG000001661
40
ENSG000001661
65
ENSG000001661
89
ENSG000001664
84
ENSG000001668
16
ENSG000001668
31
ENSG000001669
25
ENSG000001671
73
ENSG000001673
02
ENSG000001675
08
ENSG000001675
78
ENSG000001676
57
ENSG000001677
03

83953

ENSG000001677

84798

05
-1.0373

11167

FCAMR|Fc receptor, IgA, IgM, high
affinity
FSTL1|follistatin-like 1

84818

IL17RC|interleukin 17 receptor C

-1.2268

131601

TPRA1|transmembrane protein,
adipocyte asscociated 1
TKT|transketolase

-1.11974

FASTK|Fas-activated
serine/threonine kinase
TMUB1|transmembrane and
ubiquitin-like domain containing 1
NCF1C|neutrophil cytosolic factor
1C pseudogene
CARD19|chromosome 9 open
reading frame 89
UBTD1|ubiquitin domain
containing 1
RPUSD2|RNA pseudouridylate
synthase domain containing 2
ZFYVE19|zinc finger, FYVE domain
containing 19
CKB|creatine kinase, brain

-1.07824

HPS6|Hermansky-Pudlak
syndrome 6
MAPK7|mitogen-activated protein
kinase 7
LDHD|lactate dehydrogenase D

-1.07737

RBPMS2|RNA binding protein with
multiple splicing 2
TSC22D4|TSC22 domain family,
member 4
C15orf39|chromosome 15 open
reading frame 39
ENTHD2|ENTH domain containing
2
MVD|mevalonate (diphospho)
decarboxylase
RAB4B|RAB4B, member RAS
oncogene family
DAPK3|death-associated protein
kinase 3
SLC43A2|solute carrier family 43
(amino acid system L transporter),
member 2
C19orf48|chromosome 19 open

-1.04779

7086
10922
83590
654817
84270
80019
27079
84936
1152
79803
5598
197257
348093
81628
56905
146705
4597
53916
1613
124935

55

-1.53001

-1.00824

-1.22881
-1.27805

5.00E05
0.0027
5
5.00E05
5.00E05
5.00E05
5.00E05
0.0008

-1.15298

5.00E05
5.00E05
5.00E05
5.00E05
0.0043
5
5.00E05
5.00E05
5.00E05
0.0028
5
0.0008
5
5.00E05
0.0007

-1.79226

0.0001

-1.50744

5.00E05
5.00E05
5.00E05
5.00E05

-1.44697
-1.08225
-1.01157
-1.02447
-2.00337

-1.02829
-1.10143

-1.25566

-1.0446
-1.91505
-1.24864

-1.0195

0.0056

47

reading frame 48

ENSG000001677
79
ENSG000001677
97
ENSG000001678
95
ENSG000001679
62
ENSG000001680
56
ENSG000001680
71
ENSG000001680
96
ENSG000001684
87
ENSG000001685
28
ENSG000001690
26
ENSG000001691
88

3489

ENSG000001696
92
ENSG000001697
10
ENSG000001697
38
ENSG000001699
76
ENSG000001704
58
ENSG000001706
38
ENSG000001709
06

10555

ENSG000001711
05
ENSG000001712
98
ENSG000001721
83
ENSG000001723
54
ENSG000001723
75
ENSG000001725

5

IGFBP6|insulin-like growth factor
binding protein 6
CDK2AP2|cyclin-dependent kinase
2 associated protein 2
TMC8|transmembrane channellike 8
ZNF598|zinc finger protein 598

-1.10574

-1.11773

5.00E05
5.00E05
5.00E05
0.0013

LTBP3|latent transforming growth
factor beta binding protein 3
CCDC88B|coiled-coil domain
containing 88B
ANKS3|ankyrin repeat and sterile
alpha motif domain containing 3
BMP1|bone morphogenetic
protein 1
SERINC2|serine incorporator 2

-1.12471

0.0055

-1.58332

0.0039
5
0.0039
5
0.0003

MFSD7|major facilitator
superfamily domain containing 7
APEX2|APEX nuclease
(apurinic/apyrimidinic
endonuclease) 2
AGPAT2|1-acylglycerol-3phosphate O-acyltransferase 2
FASN|fatty acid synthase

-1.08125

-1.2648

929

DCXR|dicarbonyl/L-xylulose
reductase
SF3B5|splicing factor 3b, subunit
5, 10kDa
CD14|CD14 molecule

80305
4696

10263
147138
90850
4054
283234
124401
649
347735
84179
27301

-1.05986
-2.75204

-1.20393
-1.11063
-1.73007

5.00E05
0.0011

-1.21942

5.00E05

-1.47395

-1.1104

5.00E05
0.0015
5
5.00E05
5.00E05
0.0002

TRABD|TraB domain containing

-1.48765

0.0003

-1.03021

0.0045
5

3643

NDUFA3|NADH dehydrogenase
(ubiquinone) 1 alpha subcomplex,
3, 9kDa
INSR|insulin receptor

-1.09733

0.002

2548

GAA|glucosidase, alpha; acid

-1.31969

3669

-1.3279

9854

ISG20|interferon stimulated
exonuclease gene 20kDa
GNB2|guanine nucleotide binding
protein (G protein), beta
polypeptide 2
C2CD2L|C2CD2-like

5.00E05
0.0035

1521

CTSW|cathepsin W

2194
51181
83443

2783

56

-1.67319

-1.05208

-1.24667

5.00E05

-1.04602

0.0033

-1.00814

0.0001

43

5

ENSG000001726
63
ENSG000001727
24
ENSG000001732
64
ENSG000001733
69
ENSG000001733
72
ENSG000001734
57
ENSG000001735
40
ENSG000001735
46
ENSG000001747
75
ENSG000001748
86

80194

TMEM134|transmembrane
protein 134
CCL19|chemokine (C-C motif)
ligand 19
GPR137|G protein-coupled
receptor 137
C1QB|complement component 1,
q subcomponent, B chain
C1QA|complement component 1,
q subcomponent, A chain
PPP1R14B|protein phosphatase 1,
regulatory (inhibitor) subunit 14B
GMPPB|GDP-mannose
pyrophosphorylase B
CSPG4|chondroitin sulfate
proteoglycan 4
HRAS|Harvey rat sarcoma viral
oncogene homolog
NDUFA11|NADH dehydrogenase
(ubiquinone) 1 alpha subcomplex,
11, 14.7kDa
SEZ6L2|seizure related 6 homolog
(mouse)-like 2
ASPHD1|aspartate betahydroxylase domain containing 1
C11orf68|chromosome 11 open
reading frame 68
AURKAIP1|aurora kinase A
interacting protein 1
SSNA1|Sjogren syndrome nuclear
autoantigen 1
SPHK1|sphingosine kinase 1

-1.30309

ENSG000001749
38
ENSG000001749
39
ENSG000001755
73
ENSG000001757
56
ENSG000001761
01
ENSG000001761
70
ENSG000001764
54
ENSG000001769
73
ENSG000001769
78
ENSG000001770
30
ENSG000001771
06
ENSG000001775
42

26470

-1.0981

5.00E05
0.0010
5
5.00E05
5.00E05
5.00E05
0.0046

-1.31541

0.0005

-1.24525

29952

LPCAT4|lysophosphatidylcholine
acyltransferase 4
FAM89B|family with sequence
similarity 89, member B
DPP7|dipeptidyl-peptidase 7

10522

DEAF1|DEAF1 transcription factor

-1.01725

64787

EPS8L2|EPS8-like 2

-1.39058

5.00E05
5.00E05
0.0049
5
0.0013

79751

-1.57688

0.0001
5

6181

SLC25A22|solute carrier family 25
(mitochondrial carrier: glutamate),
member 22
RPLP2|ribosomal protein, large, P2

ENSG000001776
00
ENSG000001782
09

-1.01189

5339

PLEC|plectin

-1.41348

5.00E05
5.00E05

6363
56834
713
712
26472
29925
1464
3265
126328

253982
83638
54998
8636
8877
254531
23625

57

-1.52581
-1.33788
-1.0098
-1.07418
-1.07777
-1.1117
-1.1675
-1.59219
-1.18046

-1.28382
-1.0931
-1.06967
-1.36108
-1.53953

-1.53086

5.00E05
5.00E05
5.00E05
5.00E05
5.00E05
5.00E05
0.0001
5
5.00E05
5.00E05
0.0001

ENSG000001786
05
ENSG000001794
09
ENSG000001795
93
ENSG000001799
22
ENSG000001804
48
ENSG000001815
77
ENSG000001820
87
ENSG000001824
87
ENSG000001825
04
ENSG000001830
92
ENSG000001835
70
ENSG000001836
84
ENSG000001837
51
ENSG000001842
81
ENSG000001844
89
ENSG000001847
30
ENSG000001848
97
ENSG000001850
33

8225

GTPBP6|GTP binding protein 6
(putative)
GEMIN4|gem (nuclear organelle)
associated protein 4
ALOX15B|arachidonate 15lipoxygenase, type B
ZNF784|zinc finger protein 784

-1.08428

HMHA1|histocompatibility (minor)
HA-1
C6orf223|chromosome 6 open
reading frame 223
TMEM259|transmembrane
protein 259
NCF1B|neutrophil cytosolic factor
1B pseudogene
CEP97|centrosomal protein 97kDa

-1.99385

-2.03118

54039

BEGAIN|brain-enriched guanylate
kinase-associated
PCBP3|poly(rC) binding protein 3

-1.32106

5.00E05
5.00E05
5.00E05
0.0023
5
5.00E05
0.0001
5
5.00E05
5.00E05
5.00E05
0.0030
5
0.0008

10189

ALYREF|Aly/REF export factor

-1.21359

0.0002

10607

TBL3|transducin (beta)-like 3

-1.49669

10078

TSSC4|tumor suppressing
subtransferable candidate 4
PTP4A3|protein tyrosine
phosphatase type IVA, member 3
APOBR|apolipoprotein B receptor

-1.44619

-1.03817

3665

H1FX|H1 histone family, member
X
SEMA4B|sema domain,
immunoglobulin domain (Ig),
transmembrane domain (TM) and
short cytoplasmic domain,
(semaphorin) 4B
SIGIRR|single immunoglobulin and
toll-interleukin 1 receptor (TIR)
domain
IFITM2|interferon induced
transmembrane protein 2
FAAP100|Fanconi anemia core
complex associated protein 100
IRF7|interferon regulatory factor 7

5.00E05
0.0007
5
0.0002
5
5.00E05
0.0001

ENSG000001851
87

59307

ENSG000001852
01
ENSG000001855
04
ENSG000001855
07
ENSG000001856
69
ENSG000001858
03

10581

333929

SNAI3|snail family zinc finger 3

-1.06225

79581

SLC52A2|solute carrier family 52
(riboflavin transporter), member 2

-1.02906

50628
247
147808
23526
221416
91304
654816
79598
57596

11156
55911
8971
10509

80233
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-1.17819
-1.01864
-1.28387

-1.01552
-1.03373
-1.20503
-2.16027

-1.09171
-1.1535

-1.18097

5.00E05

-1.21446

0.0011

-1.04698

5.00E05
0.0028
5
0.0002
5
0.0014

-1.02877
-1.52581

0.0031
5

ENSG000001858
85
ENSG000001860
10

8519

IFITM1|interferon induced
transmembrane protein 1
NDUFA13|NADH dehydrogenase
(ubiquinone) 1 alpha subcomplex,
13
BCL9L|B-cell CLL/lymphoma 9-like

-1.3133

ENSG000001861
74
ENSG000001865
01
ENSG000001866
35

283149

-1.37879

0.0001

TMEM222|transmembrane
protein 222
ARAP1|ArfGAP with RhoGAP
domain, ankyrin repeat and PH
domain 1
TNFRSF18|tumor necrosis factor
receptor superfamily, member 18
RTN4RL2|reticulon 4 receptor-like
2
SIRT7|sirtuin 7

-1.30675

5.00E05
5.00E05

ENSG000001868
91
ENSG000001869
07
ENSG000001875
31
ENSG000001876
08
ENSG000001876
88

8784

ISG15|ISG15 ubiquitin-like
modifier
TRPV2|transient receptor
potential cation channel,
subfamily V, member 2
TMEM256-PLSCR3|phospholipid
scramblase 3
ZP3|zona pellucida glycoprotein 3
(sperm receptor)
NDOR1|NADPH dependent
diflavin oxidoreductase 1
NOC2L|NOC2-like nucleolar
associated transcriptional
repressor
TMEM120A|transmembrane
protein 120A
LONP1|lon peptidase 1,
mitochondrial
ZNF777|zinc finger protein 777

-1.68484

ENSG000001878
38
ENSG000001883
72
ENSG000001885
66
ENSG000001889
76

57048

ENSG000001890
77
ENSG000001963
65
ENSG000001964
53
ENSG000001964
98
ENSG000001965
76
ENSG000001968
43
ENSG000001968
78
ENSG000001969
24
ENSG000001971
14
ENSG000001971
50

83862

NCOR2|nuclear receptor
corepressor 2
PLXNB2|plexin B2

-1.03301

-1.11183

3914

ARID5A|AT rich interactive
domain 5A (MRF1-like)
LAMB3|laminin, beta 3

2316

FLNA|filamin A, alpha

-1.22521

84619

ZGPAT|zinc finger, CCCH-type with
G patch domain
ABCB8|ATP-binding cassette, subfamily B (MDR/TAP), member 8

-2.04932

51079

84065
116985

349667
51547
9636
51393

7784
27158
26155

9361
27153
9612
23654
10865

11194
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-1.0379

-1.10892

-1.226
-1.7492
-1.1814

-1.06984

-1.15105
-1.13303
-1.12096

0.0005
5
5.00E05

5.00E05
0.0018
5
0.0011
5
0.0001
5
5.00E05
0.0004
5
5.00E05
0.0023

-1.05362

5.00E05

-1.08651

5.00E05
5.00E05
5.00E05
0.0004
5
0.0005
5
5.00E05
0.0001

-1.0442
-1.06024

-1.37984

-1.08183

-1.24739

5.00E05
0.0003
5
5.00E05

ENSG000001972
72
ENSG000001979
03
ENSG000001980
26
ENSG000001980
55
ENSG000001985
17

246778

IL27|interleukin 27

-1.55472

85236

HIST1H2BK|histone cluster 1,
H2bk
ZNF335|zinc finger protein 335

-1.34856

-1.15645

ENSG000001989
17
ENSG000002054
14
ENSG000002116
49
ENSG000002118
93
ENSG000002118
99
ENSG000002131
45
ENSG000002136
89
ENSG000002138
53
ENSG000002139
23

51490

GRK6|G protein-coupled receptor
kinase 6
MAFK|v-maf avian
musculoaponeurotic fibrosarcoma
oncogene homolog K
C9orf114|chromosome 9 open
reading frame 114

ENSG000002140
63
ENSG000002185
37
ENSG000002219
68
ENSG000002257
83

7106

ENSG000002263
32
ENSG000002283
00
ENSG000002309
43
ENSG000002351
73
ENSG000002379
89
ENSG000002382
27

63925
2870
7975

-1.1129

-1.40139

5.00E05
5.00E05
5.00E05
5.00E05
5.00E05

-1.48285

0.001

-1.02484
IGLV7-46|

-16.0296

0.0008
5
0.0001

IGHG2|

-1.60157

0.0032

IGHM|

-1.09468

CRIP1|cysteine-rich protein 1
(intestinal)
TREX1|three prime repair
exonuclease 1
EMP2|epithelial membrane
protein 2
CSNK1E|casein kinase 1,
epsilon///CSNK1E|LOC400927CSNK1E readthrough
TSPAN4|tetraspanin 4

-1.586

5.00E05
5.00E05
0.0034
5
0.0008
5
0.0022
5

MIF-AS1|

-1.59613

3995

FADS3|fatty acid desaturase 3

-1.51122

440823

MIAT|myocardial infarction
associated transcript (non-protein
coding)

-1.24161

1396
11277
2013
1454///1028003
17

-1.27944
-1.63523
-1.18937

-1.36378

-1.49849
55009

-2.10381

101927686

C19orf24|chromosome 19 open
reading frame 24
|uncharacterized LOC101927686

51236

HGH1|HGH1 homolog

-1.15194

101928399

|uncharacterized LOC101928399

-1.12929

90120

C9orf69|chromosome 9 open
reading frame 69

-1.00007
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-1.06553

0.0004
5
0.0005
5.00E05
0.0042
5
0.0019
5
0.0063
5.00E05
0.001
0.0001
5
5.00E05

ENSG000002398
57
ENSG000002419
45

51608

GET4|golgi to ER traffic protein 4

-1.1015

5822///1027241
59

-1.74723

ENSG000002428
02
ENSG000002431
56

9907

PWP2|PWP2 periodic tryptophan
protein homolog
(yeast)///PWP2|periodic
tryptophan protein 2 homolog
AP5Z1|adaptor-related protein
complex 5, zeta 1 subunit
MICAL3|microtubule associated
monooxygenase, calponin and LIM
domain containing 3

ENSG000002497
80
ENSG000002544
52
ENSG000002545
59
ENSG000002549
86
ENSG000002560
07
ENSG000002571
56
ENSG000002576
63
ENSG000002612
36
ENSG000002617
96
ENSG000002620
49
ENSG000002624
13
ENSG000002674
36
ENSG000002675
19
ENSG000002698
58
ENSG000002699
68
ENSG000002729
16
ENSG000002738
12
ENSG000002750
74

57553

10072

-1.48415

0.0044
5
0.0009

-1.00651

5.00E05
0.0045

-1.07823

0.0002

-1.35845

0.0001

-1.1664

0.0026

DPP3|dipeptidyl-peptidase 3

-1.10415

ARAP1-AS1|

-1.71348

0.0001
5
0.004

-1.13237

0.0029

-1.03551

0.0001

23246

BOP1|block of proliferation 1

-1.50606

0.0024

100534599

ISY1-RAB43|ISY1-RAB43
readthrough

-1.10893

0.0003
5
0.0060
5
0.0005

-1.24797
-1.08612
-1.09667
284454

|uncharacterized LOC284454

-1.17642

112398

EGLN2|egl-9 family hypoxiainducible factor 2

-1.00968
-1.1508
-1.14253
-1.43518

79873

NUDT18|nudix (nucleoside
diphosphate linked moiety X)-type
motif 18

ENSG000002752
94

-1.35046

-1.08204
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0.0007
5
0.0003
5.00E05
0.0002
5
0.0008
0.0001
5
5.00E05
5.00E05

Table 2-5: Up regulated and down regulated pathway in cells infected with ankH.
Up regulated
P value
Down regulated
P value
Pathway
pathway
Development
1.338e-9
Transcription, HIF-1
2.822e-15
positive regulation
targets
of STK3/4 (Hippo)
pathway and
negative regulation
of YAP/TAZ
function
Transport clathrin
2.291e-9
Immune response,
1.745e-14
coated vesicle cycle
IL-3 signaling via
JAK/STAT, p38,
JNK, and NFκB
Apoptosis and
9.334e-9
Immune response,
1.270e-11
survival, FAS
IL-1 signaling
signaling cascades
pathway
Immune response,
5.959e-8
Immune response,
1.397e-11
antigen presentation
IL-10 signaling
by MHC class I:
pathway
cross-presentation
Signal transduction,
6.740e-8
Apoptosis and
2.725e-11
JNK pathway
survival, antiapoptotic
TNFs/NFκB/Bcl-2
pathway
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Figure 2-4. Cytokine production in cells infected with WT or ∆ankH strains of L.
pneumophila. (A-H) HMDMs were infected with either the WT or ∆ankH strains of L.
pneumophila for 6 hours. Supernatants were collected and centrifuged to remove
extracellular bacteria and cell debris. Samples were then used for Milliplex assay and
cytokine concentrations were determined per assay instructions. The results are
representative of one experiment performed in triplicate. Statistical analysis was
performed using Student t-test where *, P < 0.05.
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The crystal Structure of AnkH
AnkH is one of a few of the ~330 Legionella effectors required for intracellular
growth within amoebae hosts and human macrophages [192, 210]. To get more insight
into possible cellular function of AnkH, we have determined its three-dimensional crystal
structure. AnkH is an α/β fold protein and contains a total of 21 α-helices and seven βstrands (Fig. 2-5A). AnkH consists of 3 domains: N-terminal ankyrin domain (α1-8, red),
the middle domain (α10-17 and β3-7, cyan and magenta) and the cap domain (β1-2, α9
and α18-21, wheat [186, 187]. The N-terminal domain contains ankyrin repeats with four
helix-turn-helix repeats (α1-α8, residues 1-122) (Fig. 2-5B). The first repeat is somewhat
distorted and has shorter α-helices. The ARD is followed by a 4-turn-long helix α9 and an
extended β-hairpin (β1-β2, residues 123-162) leading to the middle domain (Fig. 2-5A).
This domain (residues 163-361) contains a central 5-stranded antiparallel β-sheet, β3-β7
and extended by helix α12. The β-sheet is flanked by two layers of two helices (inner
α11, α16 and outer α10, α17) on one side and two helices α14-α15 on the other side. The
C-terminal domain (residues 362-461) contains a five-helix bundle (Fig. 2-5A) and packs
tightly together with α9 and the following β-hairpin forming one domain. The N- and Cterminal domains pack end to end into a crescent shape (Fig. 2-5A). The middle domain
forms an independent insertion abated to the side of the ARD that is typically functioning
as the protein binding surface. The long loops emanating from the ARD, usually involved
in protein-protein interactions, face the middle domain.
The inserted middle domain of AnkH has a cysteine protease fold
To gain insight into possible functions of the middle and cap domains we have
searched for their structural homologs using the Dali server [244]. The middle (insertion)
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domain showed structural similarity to several proteins with cysteine protease fold albeit
with relatively low scores. This cysteine protease-like domain (CPLD) is most similar to
the outer protein D (XopD, PDB ID: 2OIX) from bacterial plant pathogen Xanthomonas
campestris pv. Vesicatoria [245-247] (Fig. 2-5C). It also shows similarity to a domain of
another Legionella pneumophila effector, RavZ [248, 249].
XopD belongs to the ubiquitin-like-specific protease 1 family [250] and is
classified within Clan CE in the MEROPS database [251], with the catalytic triad is
arranged in the order of histidine, glutamate/aspartate/asparagine and cysteine. Cysteine
functions as a nucleophile while histidine serves as a general base and is in turn stabilized
by glutamic acid/aspartic acid [250]. The structure-based sequence identity between the
aligned regions of CPLD and XopD is only ~12%, nevertheless three β-strands and two
α-helices are structurally similar between AnkH and XopD (Fig. 2-5C), with His243,
Asp258 and Cys324 of AnkH superposed on the catalytic triad of XopD. The histidine
resides on the N-terminal end of the conserved strand within the protease fold (β4 in
AnkH, Fig 2-5A). The stabilizing aspartic acid sits at the C-terminal end of the conserved
antiparallel strand (β5 in AnkH, Fig 2-5A). The cysteine nucleophile is at the end of a
long loop leading to the penultimate helix of the protease fold (Fig. 2-5A). The
orientation of these three sidechains in AnkH deviates from the active configuration and a
small rearrangement of the triad sidechains has to occur to attain the active state (Fig. 25C). The fold of AnkH CPLD was recognized due to very low sequence identity to other
cysteine protease and is not yet classified in the peptidase database MEROPS [252],
which already includes several other peptidases from the Legionella species (data not
shown).
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Figure 2-5. The crystal structure of AnkH. (A)AnkH consists of 3 domains: N-terminal
ankyrin domain (α1-8, red), the cysteine proteinase-like domain (α10-17 and β3-7, cyan
and magenta) and the cap domain (β1-2, α9 and α18-21, wheat). Inset shows the closeup
of the putative catalytic triad residues H243, D258 and C324. The HIF hydroxylation
sites (N59 and N92) are located within the N-terminal domain and are shown in a sphere
representation (blue and red). (B) Primary sequence of ankryin domain. The length of
each ankryin repeat was determined using the consensus sequence based on statistical
analysis on 4,000 ankryin repeat sequence from the PFAM database as proposed by
Mosavi et al [217]. Highlighted (colored) letters correspond to α-helices for each
domain. The conserved residues are underlined, and the a-helices are shown as cylinders
(C) Superposition of AnkH with Xanthomonas XopD C470A mutant. Cartoon diagram of
superposed AnkH cysteine protease-like domain (residues 163-342, orange) and
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Xanthomonas XopD C470A mutant (green, PBD ID:20IX, residues 336-515). The three
β-strands and two α-helices that form the core of the domains and overlap well are
marked. Inset shows the closeup of the catalytic triad. In AnkH it consists of His243,
Asp258 and Cys324 and in XopD these residues are His409, Asp429 and Cys470.

Structure-function of AnkH
The structure of AnkH suggested that it binds cellular target(s) through the βhairpin loops within ARD domain and has a predicted proteolytic activity (Fig. 2-5A). To
better understand the roles of the AnkH domains and to validate its structure, a total of 12
residues were chosen for single substitutions based on their location within a specific
domain (Table 2-6 and Fig. 2-5). The substituted residues included residues on the
extended β-hairpin loops of ARs (Fig. 2-1 & Fig.2-5B), the putative cysteine protease
catalytic triad and two asparagine residues (N59 and N92) that have been reported to
undergo asparagine hydroxylation, which impacts protein-protein interactions [179].
Figure 2-6A illustrates each of the ARDs. Figure 2-6B & C illustrate the location of each
substitution made within the ARDs. The mutations had no detectable effect on stability of
the variant proteins in L. pneumophila (Fig. 2-6D) or during transient transfection (Fig.
6E).
HEK293T cells were co-transfected with LARP7 and either native AnkH or
AnkH containing substitutions within the β-hairpin loops of the ARDs then immuneprecipitated. Our data showed that substitutions of residues within the ARD3, specifically
Asn97, diminished LARP7-AnkH interaction (Fig. 2-6F). In contrast, substitution of 30,
31, 33, 63, 64, or 96 resulted in enhanced binding between LARP7 and AnkH (Fig 2-6F).
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Table 2-6: Point mutants generated in different domains of AnkH. ANK1,2,3
designate ankyrin repeat 1,2,3.
ANK1
E30T
Y31S
F33A
E30T/Y31S/F33A

ANK2
V63Y
T64E
V63Y/T64E

ANK3
R96A
N97V
R96A/N97V

68

Asn Hydrox
N59A
N92A
N59A/N92A

Cysteine-protease
H243D
D258A
C324S
H243D/D258A/C324S

Figure 2-6. Substitutions in ARDs alters binding efficiency of AnkH and LARP7.
(A) The ankryin domain of AnkH shown as ribbon diagram. The ankyrin domain
consists of four ankryin repeats: N-cap, repeat 1, repeat2 and C-cap. (B&C) Crystal
structure of AnkH illustrating different locations within the ARDs where residues were
substituted. (D) Bacterial lysates from WT L. pneumophila and each of the AnkH
substitution mutant strains were tested by immunoblot for AnkH to determine protein
stability. Cell lysates were immunoblotted to detect the presence of AnkH using goat αAnkH (53, 56). Equal number of bacteria were lysed for each strain. (E) HEK293T cells
were transiently transfected with 3xFLAG-AnkH or the indicated 3xFLAG-AnkH
substitution mutants and c-myc-LARP7. Densitometry was determined with actin ratio.
(F) Cell lysates were immunoprecipitated with anti-FLAG antibody, and the co-IP was
immunoblotted to detect the presence of AnkH and LARP7. Densitometry of the blots
was determined as LARP7 to AnkH ratio. Results are representative of two independent
experiments.

In order to determine if the substitutions affected the function of AnkH in
intracellular replication of L. pneumophila, hMDMs were infected with the WT strain,
the ∆ankH null mutant, ∆ankH mutant complemented with the WT allele of ankH or the
substitution variants of AnkH. We first determined if the mutated constructs were
translocated by the T4SS. One residue from each ANK domain (E30T, V63Y, N97V)
was selected for mutation (Figure 2-7A&B). Translocation was determined using Cyareporter fusions and measurement of cAMP which showed that all three representative
mutant constructs were translocated (Figure 2-7A) and produced at equivalent
concentrations by L. pneumophila (Figure 2-7B). Our data showed that substitution in the
β-hairpin loop of ARD3, which led to a reduced binding of LARP7 to AnkH, resulted in
reduced intracellular growth of L. pneumophila (Fig. 2-8). All other residues selected for
substitutions were partially required for various degrees for AnkH function in
intracellular replication, since introducing these mutations resulted in a various degrees of
partial replication defect compared to the WT strain (Student t-test p < 0.05) (Fig. 2-8)
(Table 2-6). Therefore, we conclude that the ARD, in particular Asn97, cysteine-like
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Figure 2-7. Translocation of AnkH ANK domain substitution mutants. (A) U937
cells were infected with WT or dotA strains of L. pneumophila harboring Cya contructs
of full-length AnkH, RalF, AnkHE30T, AnkHV63Y, AnkHN97V at an MOI of 10 for 1
hour. Cells were lysed and cAMP levels were measured. (B) Bacterial strains used for
cAMP assay were used to confirm protein production by L. pneumophila. 1X106 bacteria
were lysed and used for western blot analysis. The results are representative of
experiment performed in triplicate. Statistical analysis was performed using Student t-test
where *, P < 0.05.
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Figure 2-8. Structure-function of AnkH in intracellular growth of L. pneumophila
within hMDMs. Intracellular growth kinetics were determined for WT strain, the ankH
mutant, the ankH mutant complemented with the WT allele (c.ankH), or with single and
multiple substitution variants as indicated. All strains in all the panels were tested using
the same WT control. (A) Mutations within first ANK repeat, (B) second ANK repeat,
(C) third ANK repeat, (D) asparagine hydroxylation motif and (E) cystine like protease
pocket. The results are representative of three independent experiments performed in
triplicate. Statistical analysis was performed using Student t-test where *, P < 0.05.
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protease domain, and the asparagine hydroxylation motifs are all required for the function
of AnkH in intracellular proliferation of L. pneumophila within hMDMs.

Materials and Methods
Bacterial strains and cell culture
L. pneumophila strain AA100/130b (BAA-74; American Type Culture Collection) and
the isogeneic mutant’s dotA, ankH, and complemented ankH mutants were grown on
BCYE agar plates for 3 days at 37°C prior to use in infections, as described previously
[54]. E. coli strain DH5-α was used for cloning purposes. Human monocyte-derived
macrophages (hMDMs) were cultured using RPMI1640 media (Gibco), as described
previously [150]. Maintenance of HEK293T cells was performed as previously described
[150]. All methods were carried out and approved in accordance to the University of
Louisville Institutional Review Board guidelines and blood donors gave informed
consent as approved by the University of Louisville Institutional Review Board (IRB #
04.0358).
DNA manipulations
DNA manipulations and restriction enzyme digestions were performed using standard
procedures [150, 253]. Restriction enzymes and T4 DNA ligase were purchased from
NEB (Madison, WI). Plasmid preparations were performed with the PureLink HiPure
Plasmid Maxiprep kit (Invitrogen). Purification of DNA fragments from agarose gels for
subcloning was carried out with the QIAquick gel purification kit (Qiagen Inc, Valencia,
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CA). Generation of AnkH substitution mutants was achieved using primers listed in
Table 2-7 and described previously [150, 186].
Table 2-7. Primers used in this study.
ankHE30T
ankHE30T
ankHY31S
ankHY31S
ankHF33A
ankHF33A
ankHV63Y
ankHV63Y
ankHT64E
ankHT64E
ankHR96A
ankHR96A
ankHN97V
ankHN97V
ankHN59A
ankHN59A
ankHN92A
ankHN59A
ankHH243D
ankHH243D
ankHD258A
ankHH243D
ankHC324S
ankHC324S

F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R

CATATGGTTTTACTCCCCTCATAG
TATCGATATCATCCAAAGATTCCC
CTGGTTTTACTCCCCTCATAGAGT
ATTCATCGATATCATCCAA
CTACTCCCCTCATAGAGTGTGCCA
CACCATATTCATCGATATCA
ACACAGGACGCACTCCATTACATT
AGTCTGGCTTGTTGATATCCACTT
AAGGACGCACTCCATTACATTGGG
CGACGTCTGGCTTGTTGATA
CTAATGGTCTTTGTGTATTGGTTT
CAGTGTAGGCATTAGGATCAGCGC
TTGGTCTTTGTGTATTGGTTTATC
CACGAGTGTAGGCATTAGGA
CAAGCCAGACGTCACAGGACGC
CGATATCCACTTTTCGAGCAATTAA
TTGCCTACACTCGTAATGGTCTT
CAGGATCAGCGCCGTAGGTTAA
AATGCCTTATGCTTTGTC
GCCACGACTCGCCGCAGG
CCAGGGGTGAAAATAGCTTACAAG
CAATTTTTGCCCACCACTGGTGAT
AGTTCGTGGGCTAATGTG
ATTTCCACTAATTTGAGA

*All primers are 5’-phosphorylated. Orientation: F, forward; R, reverse

Translocation Assay
Legionella pneumophila strains AA100-Ralf-Cya, ∆dotA-RalF-Cya, AA100-AnkH-Cya,
∆dotA-RalF-Cya, AA100-AnkHE30T-Cya, AA100-AnkHV63Y-Cya, and AA100AnkHN97V-Cya were grown for on BCYE for 3 days at 37°C prior to infection. U937 cells
were plated in 12 well plates at a concentration of 2 X 106 in triplicates and infected with
L. pneumophila at an MOI of 10 for 1 hour. Cells were lysed using HCl + 0.1% Triton-X.
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Levels of cAMP in cell lysates was analyzed using Direct cAMP ELISA (Enzo Life
Sciences) kit per instructions.
Transfection of HEK293T cell
HEK293T cells were grown to ~70% confluent and plated onto poly-L-lysine-treated 24
well plates. Following 24 h of incubation, HEK293T cell monolayers were transfected
with ~2 µg of plasmid DNA/well by using polyethylenimine (Polysciences) and
OptiMem (Gibco) for 24 h, as described previously [89, 186]. The c-myc-LARP7
plasmid was a gift from B. Matija Peterlin, University of California, San Francisco.
Confocal laser scanning microscopy
Processing of transfected cells for confocal microscopy was performed as we described
previously. Briefly, monolayers were permeabilized and fixed using 100% methanol held
at -20°C for 5 min, and then blocked and labeled with mouse-anti-FLAG (1/200 dilution,
Sigma, in 3% BSA-PBS), and rabbit-anti-Myc (1/200 dilution, ProteinTech, in 3% BSAPBS). Cells were counter-labelled with Alexa-Fluor 488 anti-mouse antibody (1/4000
dilution, Invitrogen, 3% BSA-PBS), Alexa-Fluor 555 anti-rabbit antibody (1/4000
dilution, Invitrogen) and DAPI to stain the nuclei. Monolayers were examined by
confocal microscopy. A total of 100 cells for each replicate were counted for presence or
absence of localization.
Intracellular Replication
The wild type strain and the isogenic mutants, dotA and ankH, and the complemented
ankH mutants were grown on BCYE for 3 days at 37°C prior to infection and used to
infect hMDMs. A total of 1 X 105 host cells (hMDMs) per well were plated in 96 well
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plates and infected with L. pneumophila at an MOI of 10 for 1 h and then treated for 1 h
with gentamicin to kill remaining extracellular bacteria. Over a 24 h time course, the host
cells were lysed with sterile water and L. pneumophila CFUs were determined by plating
serial dilutions onto BCYE agar. Experiments were performed in triplicate.
Yeast two-hybrid (Y2H) analysis
The Matchmaker Gold Two-Hybrid system (Clontech) was used to screen host proteins
that interact with the AnkH protein per manufactures instructions. Full length AnkH
coding sequence was amplified, sequenced and cloned into the pGBKT7 bait vector
(Clontech) and transformed into the AH109 yeast strain (Clontech). A normalized
universal human cDNA library in pGADT7 was purchased (Clontech) to use as potential
prey targets. The library and bait containing AH109 were mated and resulting colonies
were screened per manufactures instructions. Plasmids from positive clones were isolated
using yeast lysis buffer and glass beads. Isolated prey plasmid and bait plasmid were used
to co-transform the AH109 yeast strain. Transformants were selected by growing the
yeast on SD medium lacking His, Leu and Trp (SD-His/-Leu/-Trp) (Clontech). Positive
colonies were then transferred to SD-Ade/-His/-Leu/-Trp plates containing 5-bromo-4chloro-3-indoxyl-α-D-galactopyranoside (X-α-gal) (GoldBio). Blue colonies were
selected for plasmid isolation. Isolated plasmids were then sequenced to determine the
human genes.
In vivo Co-immunoprecipitation
HEK293T cells were transfected with 3XFLAG-AnkH, BAP, and c-myc-LARP7 for 24 h
and collected in lysis buffer, as described previously [177, 254]. FLAG-tagged and myc-
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tagged proteins were immunoprecipitated by using anti-FLAG M2 magnetic beads
(Sigma) or SureBeads Protein G Magnetic Beads (BioRad) crosslinked with anti-myc
antibody (ProteinTech).
Antibodies and western blot analysis
Legionella pneumophila strains were lysed using B-PER (Thermo Scientific) and heated
at 99°C for 5 minutes in sample buffer. 1 X 106 bacteria were loaded per lane and
separated by 10.4 to 15% SDS-PAGE (BioRad), and transferred onto a polyvinylidene
difluoride (PVDF) (BioRad) membrane, as described previously [254]
Immunoprecipitated proteins were heated at 99°C for 5 minutes in sample buffer,
separated by 10.4 to 15% SDS-PAGE (BioRad), and transferred onto a polyvinylidene
difluoride (PVDF) (BioRad) membrane, as described previously [254]. Anti-Flag
(Sigma) used at 1:1000 dilution, anti-myc (60003-2-Ig) (ProteinTech) used at 1:1000
were incubated overnight in 8% milk at 4°C overnight. Anti-LaminB (13435) (Cell
Signaling) was used at 1:1000 dilution. Anti-HEXIM1 (15676-1-AP), anti-LARP7
(17067-1-AP) and anti-MePCE (14917-1-AP) were purchased from ProteinTech and
used at a 1:500 dilution. Anti-CDK9 (sc-13130) was purchased from Santa Cruz and used
at a dilution of 1:200. Anti-CyclinT1 (sc-271348) was purchased from Santa Cruz and
used at a dilution of 1:100. Goat Anti-AnkH antiserum was produced at Cocalico
Biologics and was used at a dilution of 1:100 [186, 187].Cya-hybrids were detected using
monoclonal M-45 antibody at a dilution of 1:50 [53].
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RNA Isolation, Reverse transcription and Real-Time PCR
Total RNA was extracted using Trizol reagent (Invitrogen). cDNA synthesis was
performed with 1 μg of total RNA using iScriptTM cDNA Synthesis kit (Bio-Rad)
according to the manufacturer’s instructions. Endogenous mRNA levels were measured
by real-time PCR analysis based on SYBR Green detection (Fermentas) with the Bio-Rad
MiniOpticon real-time PCR system.
RNA Seq
Libraries were prepared using the TruSeq Stranded mRNA LT Sample prep kit Set A or
Set B with poly-A enrichment (Illumina). One microgram of sample (in a volume of
50µl) were treated with RNA purification beads and denatured for 5 minutes at 65°C.
Then the supernatant was discarded, and the beads were washed with bead wash buffer.
Captured polyadenylated RNA was eluted using Elution buffer at 80°C for 2 min. mRNA
is further purified in a second bead clean-up, as well as fragmented and primed during
elution by adding 19.5µg of Elute, Prime, Fragment High Mix to the beads and
incubating the samples for 8 minutes at 94°C. After fragmentation, 17µl of supernatant is
removed from the beads and we proceeded immediately to synthesize first strand cDNA.
Following the protocol, 8µl of First Strand Synthesis Mix Act D and SuperScript II mix
(Illumina) was added to each sample and heated on a thermocycler using preprogramed
thermal conditions. Once the reaction finished and reached 4°C, we immediately
proceeded for second strand cDNA synthesis.
Diluted end repair control and Second Strand Marking Mix were added, mixed well and
incubated in a pre-heated thermocycler at 16°C for one hour. The DNA was purified
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using Agencourt AMPure XP Beads (Beckman). Finally, samples were eluted with
resuspension buffer and 15µl of elute was collected and stored at -20°C.
A-Tailing control and A-Tailing mix were added to the purified samples and the samples
were incubated on the preprogrammed thermal cycler. Once the incubation is done, we
proceeded immediately to ligate adapters. Diluted ligation control, Ligation Mix and
barcodes were added and incubated in a pre-heated thermocycler at 30°C for 10 minutes.
Stop Ligation Buffer was immediately added to each sample and mixed well. Then the
ligated samples were purified using Agencourt AMPure XP Beads. We eluted with 50µl
of resuspension buffer and the elute was again purified for a second time using Agencourt
AMPure XP Beads. Afterwards, the final elution, consisting of 20µl of the elute was
collected and used for DNA enrichment. Samples were barcoded with Illumina TruSeq
Adapters as listed Table 2-8. A complete list of the barcode sequences can be obtained
from the Illumina support site (http://support.illumina.com/dam/illuminasupport/documentation/chemistry_documentation/experiment-design/illumnia-adaptersequences_1000000002694-01.pdf).
Table 2-8: Sample and Barcode Information
No.
1
2
3
4
5
6
10
11
12

Sample-BMDM
Control_1
Control_2
Control_3
Wildtype_1
Wildtype_2
Wildtype_3
ankH_1
ankH_2
ankH_3
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Barcodes Used
2
4
5
6
7
12
16
18
19

PCR Primer Cocktail Mix and PCR Master Mix were added to the samples and incubated
on a preprogrammed thermal cycler. Then the samples were purified using Agencourt
AMPure XP Beads. Finally, 30µl of eluted library was collected and stored -20°C.
Libraries were validated by quality where size, purity, and semi quantitation was
performed on an Agilent Bioanalyzer using the Agilent DNA 1000 Kit. The final
fragment size for all the samples was approximately 300bp which is expected according
to the protocol. Libraries were also validated by quantity. Sequencing library quantitation
was performed by qPCR using he KAPA library Quantitation Kit (KAPA Biosystems)
for Illumina Platforms. The standard curve method was used for quantitation using 1-5
DNA standards that came with the kit.
Ten microliters of sample was transferred from the wells to a new MIDI plate. We then
normalized the concentration of the libraries to 10nM using Tris-HCl 10mM, pH 8.5 with
0.1% Tween 20. Five microliters of each sample was then transferred to be pooled into a
new LowBind 1.5ml micro centrifuge tube for a total volume of 60µl pooled 10nM
library. Then, 4nM dilution was made from the 10nM pooled library by diluted with TrisHCl 10mM, pH 8.5 with 0.1% Tween 20.
A total volume of 1.3ml of 1.8pM denatured library is needed for sequencing using v2
kit. Pooled 4nM library was denatured by mixing with diluted NaOH and incubated at
room temperature for 5 minutes. Two hundred millimolar Tris HVl, pH 7.0 was then
added. The reaction mixture was diluted to 20pM using a pre-chilled Hybridization
buffer. Twenty picomolar denatured library was further diluted to 1.8pM using the same
Hybridization buffer. Before loading onto the reagent cartridge, 1.3 µl of denatured 20pM
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Phix control was added to the 1299µl of denatured 1.8pM library to a total volume of 1.3
ml for the sequencing run.
Sequencing was performed on the University of Louisville Center for Genetics and
Molecular Medicines (CGeMM) Illumina NextSeq 500 using the NextSeq 500/550 1x75
cycle High Output Kit v2.
Milliplex Assay
Human monocyte derived macrophages were plated at a concentration of 2X106 in 12
well plates. Cells were infected with either WT or ∆ankH strain of L. pneumophila for 6
hours at an MOI of 10. Cell supernatants were collected and used for assay. Milliplex
assays (Millipore) were performed according to the manufacturer’s instruction. Standards
or culture supernatant samples were mixed with antibody-bound magnetic beads, and
incubated overnight at 4 °C. Beads were washed and then incubated with the biotinylated
detection antibody for one hour at room temperature. The beads were incubated with
phycoerythrin-labeled streptavidin for thirty minutes at room temperature and the median
fluorescent intensities were quantified with a Bio-plex 200 analyzer and analyzed with
Bio-plex Manager 6.0 software. All samples were measured in duplicate.
RNAi Knockdown
Human LARP7 siRNA Lentivector against four LARP7 target sequences and scrambled
siRNA GFP Lentivector were used with pLEnti-P2A, pLenti-P2B and Lentifectin to
produce lentiviral particles per manufactures protocol (Applied Biological Materials,
Inc). Lentiviral particles were mixed with complete RPMI (Corning) containing 8 µg/ml
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polybrene (Milipore). Virus and media mixture was added to wells at 50 µL mixture per
1 mL of cells and incubated for 24 h.
Cloning ankH and protein expression
The ankH gene (Uniprot: Q5ZT65) from Legionella pneumophila strain Philadelphia 1
was cloned into vector pMCSG7, a derivative of vector pET-21a adapted for ligationindependent cloning (PMID: 18988021). This plasmid was then transformed into BL21
(DE3). The expressed protein contained a TEV-cleavable 6X-histidine tag at the Nterminus. For large-scale expression, a 15 mL overnight culture in LB was inoculated
into 1 L of terrific broth medium (Bio Basic Inc. Markham, Ontario). The inoculated
culture was grown at 37oC and was induced with 1 mM isopropyl β-D-1thiogalactopyranoside when OD600 reached 0.6 and the temperature reduced to 18oC for
overnight growth. The cells were harvested by centrifugation at rpm of 9,000 x g for 15
min.
For expression of the Se-methionine derivative, the cell pellet from 100 mL of overnight
culture grown in LB media was inoculated into 1 L of M9 minimal media. After shaking
at 37oC until OD600 reached 0.6, a mixture of L-amino acids (100 mg of lysine,
phenylalanine, and threonine; 50 mg of isoleucine, leucine, and valine) and 60 mg of Semethionine were added to the culture. Protein expression was induced with by adding 1
mM of Isopropyl β-D-1-thiogalactopyranoside after 15 minutes. The induced culture
grew overnight at 18oC and the cells were harvested by centrifugation at rpm of 9,000 x g
for 15 min.
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Protein purification
The cell pellet was re-suspended in lysis buffer (50 mM Tris-HCl buffer pH 8.0, 10%
glycerol, and 0.1% Triton X). The cells were lysed in a cell disruptor (Constant Systems
Ltd). The cell debris was removed by centrifugation at rpm of 31,000 x g for 30 min. The
resulting supernatant was applied to a 3 mL TALON cobalt metal-affinity column
(Clontech). The column was washed with 5 column volumes of standard buffer (20 mM
Tris pH 8.0 and 50 mM NaCl). A step gradient containing 100 mM and 200 mM
imidazole in standard buffer was used to elute the His-tagged protein. Fractions
containing AnkH were pooled and loaded on a Superdex 200 10/300 GL column (GE
Healthcare) equilibrated with crystallization buffer (15 mM Tris-HCl pH 8.0 and 100
mM NaCl). AnkH-containing fractions were pooled and concentrated to 5 mg/mL in a
Millipore centrifugal filter with a molecular weight cut-off of 10,000 Da forcrystallization trials. The concentration was measured using the Nanodrop UV
Spectrophotometer (Themo Scientific) using extinction coefficient of 70,250 for AnkH
calculated by the ProtParam [255].
Protein crystallization and data collection
Initial crystals were obtained by screening and optimized using the 24-well plate format.
The best crystals were obtained by the hanging-drop method by mixing 1 μL of protein
solution and 1 μL of reservoir solution containing 1.0 M ammonium tartrate dibasic, pH
7.0. The drop was incubated over 0.5 mL reservoir solution. The crystals were
cryoprotected in solution containing 70% of reservoir solution and 30% glycerol. Crystals
were flash cooled in liquid nitrogen and diffraction data collected at the 08ID and 08BM
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beamlines at the Canadian Light Source. Data were processed and scaled with XDS. The
same procedure was followed for the Se-methionine labeled derivative.
Structure determination
The native and SeMet dataset were indexed, integrated and scaled using Program
HKL3000 [256]. Experimental phases were obtained by single-wavelength anomalous
dispersion (SAD) method and the structure was solved using Program HKL3000. The
auto-built model from HKL3000 was ~90% complete and the remaining 10% of the
molecule was built manually using program Coot (PMID: 20383002). The refinement
was done using program suite Phenix [257]. The model contains residues 1-461 and was
refined to Rwork=0.172 and Rfree=0.210. The geometry was validated with the program
MolProbity [258]. The pertinent details of data collection and refinement are listed in
Table 2-9. The coordinates and structure factors were deposited with the Protein Data
Bank with the code 6MCA. Crystal structure was modeled using Chimera software
(UCSF) and structure similarity to other peptidases was determined using peptidase
database MEROPS [252].
Table 2-9. Data collection and refinement
SeMet AnkH

Native AnkH

Data collection statistics
Space group

P65 2 2

P65 2 2

a,b,c (Å), γ (º)

100.3, 100.3, 266.6, 120

102.1, 102.1, 266.0, 120

Wavelength (Å)

0.9788

0.9795

Resolution (Å)

50-2.9 (2.95-2.90)

51.1-2.45 (2.49-2.45)

Total Reflections

930045

643977

Unique reflections

18541

30933
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Rmeas

0.117 (0.882)

0.082 (0.855)

Completeness (%)

96.8 (94.7)

97.3 (94.4)

Redundancy

50.2 (49.8)

20.8 (21.3)

I/σ(I)

49.3 (6.0)

48.1 (6.1)

Wilson B (Å2)

47.0

32.4

Refinement statistics
Rcryst d / Rfree e (%)

0.172 / 0.210

Rmsd on bonds (Å)

0.004

Rmsd on angles (º)

0.601

Favored (%)

98.25

Allowed (%)

1.75
6MCA

PDB code

Statistical analysis
All experiments were performed at least three independent biological repeats, and the
data shown are representatives of one experiment. To analyze for statistically significant
differences between three sets of data, the two-tailed Student’s t-test was used, and the pvalue was obtained.
Data Availability
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CHAPTER 3:
DISCUSSION
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An important step for the survival and replication of intracellular pathogens after
infection of a host cell is to create an environment that supports the pathogen life cycle.
Establishment of this environment is commonly accomplished through effector proteins
[137, 138]. Legionella is a unique genus in that it codes for roughly 18,000 effectors
proteins, many of which contain eukaryotic like protein domains and motifs. Among the
18,000 effector proteins, AnkH is the only effector conserved among all Legionella
species, as well as other pathogens that harbor the Dot/Icm secretion system [137, 138].
While many L. pneumophila effectors are dispensable for intracellular growth of the
pathogen in macrophages [156, 210, 259, 260], the AnkH effector plays an important role
in intracellular growth of L. pneumophila within amoeba hosts and within macrophages
[186, 187]. In addition, the high conservation of AnkH among many pathogenic obligate
and facultative intracellular species of bacteria [137, 138] suggests it has a role in
modulating an evolutionarily conserved eukaryotic process exploited by various obligate
and facultative intracellular pathogens that translocate the AnkH effector by the Dot/Icm
secretion system. Blast searches [261] with the nucleotide sequence of AnkH shows that
in addition to various Legionella species homologous proteins are also found in
Gammaproteobacteria species, Coxiella species, Candidatus berkiella, Rickettsia species,
Aquicella, and Legionella micdadei [259].

AnkH is one of the many L. pneumophila effectors that contain eukaryotic like
protein domains. AnkH contains ankyrin repeat domains (ARD) which are the most
commonly found eukaryotic like protein domains found among Legionella effectors. The
ARDs are capable of binding to multiple protein partners. Due to this possibility, it is
likely that AnkH has multiple host interacting partners. We confirmed the host LARP7 is
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an interacting partner for AnkH in HEK293T cells. LARP7 is a component of the 7SK
snRNP complex which controls pausing of RNA polymerase II at the initiation of
transcriptional elongation (see model in Fig. 3-1) [227-229]. Formation of the 7SK
snRNP core complex (7SK, LARP7 and MePCE) enables recruitment of the P-TEFb and
HEXIM1/2 to the complex [228, 231, 234-237]. Binding and sequestration of P-TEFb
within the 7SK snRNP complex results in inhibition of its kinase activity and continued
pause in Pol II transcription elongation [230, 233, 238, 239]. Various stimuli trigger the
release of P-TEFb from the 7SK snRNP complex, leading to activation of its kinase
activity, which is responsible for phosphorylating RNA pol II. This phosphorylation
event ends the paused state of RNA pol II leading to productive transcriptional elongation
[240, 241]. While LARP7 immunoprecipitates with AnkH, other components of the 7SK
snRNP complex were not able to consistently be immunoprecipitated with AnkH,
indicating that AnkH does not interact with a fully formed and functional 7SK snRNP
complex.

The cellular localization of LARP7 corresponds to its function. Transcription
takes place in the nucleus of cells and that is where LARP7 and the 7SK snRNP complex
are found. Pathogenic effectors that modulate host transcription machinery are limited
and the manipulation of the host 7SK snRNP complex via LARP7-AnkH interaction
identifies a novel effector mechanism for host transcription control during infection.
However, it is not known whether the interaction between AnkH and LARP7 and
potentially other host targets has evolved during interaction of L. penumophila with
various protist hosts in the aquatic environment to modulate amoeba hosts-specific gene
transcription [137, 138, 210]. LARP7 is conserved in both human cells and amoeba.
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Therefore, it is highly possible that some of the transcriptional activity impacted by the
interaction of AnkH with LARP7 and other host targets in human macrophages may
simply be an evolutionary accident [137, 138, 210]. Since knockdown of LARP7 results
in a significant decrease in the intracellular replication of both WT and ∆ankH null
mutant of L. pneumophila, it is likely that the AnkH-LARP7 interaction promotes
transcription of genes involved in permissiveness to L. pneumophila in evolutionarily
distant hosts. It was unexpected that LARP7 knockdown caused a significant decrease in
intracellular replication of ∆ankH mutant. This could be explained by the hypothesis that
AnkH does not interact with all LARP7 available within a host cell, which could create a
balance between pause of transcription elongation and relief of the pause in elongation
that creates a favorable environment for L. pneumophila replication. When AnkH is
deleted and LARP7 is knocked down there is no longer a transcriptional balance. This
may result in the decrease in replication as the result of unchecked transcription in hose
cells leading to the alteration of many processes involved in permissiveness of the host
cell to L. pneumophila.
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Figure 3-1. Working Model of AnkH-LARP7 Interaction. In un-infected cells or
during ΔankH mutant infection of HEK293T cells, formation of the 7SK snRNP begins
when the 5’ methyl capping enzyme (MePCE) and LARP7 are recruited to the 7SK
snRNA forming the core of the 7SK snRNP. After core formation, the HEXIM 1/2
dimers as well as the P-TEFb (Cdk9 & CyclinT1) kinase are recruited to complete the
7SK snRNP complex, which prevents transcription elongation by holding RNA
Polymerase II in a paused state. During infection with WT L. pneumophila, AnkH is
trafficked to the nucleus where it interacts with a portion of available LARP7 in the cell.
The interaction between AnkH and LARP7 results in a partial inhibition of the 7SK
snRNP complex function leading to enhanced transcriptional elongation by blocking the
recruitment of HEXIM1/2 and P-TEFb. The remaining LARP7 present in the cell
(fraction that does not interact with AnkH) is available to interact with other components
of the 7SK snRNP complex to pause transcription elongation by preventing P-TEFb from
phosphorylating RNA Polymerase 2 keeping the polymerase in a paused state. This
balance between the pause and relief of the pause in transcriptional elongation results in
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transcriptional reprogramming within host cell that enhance permissiveness to L.
pneumophila infection. There are likely other unidentified substrates of AnkH that could
aid in this process or could act independently of the interaction with LARP7. The effect
on amoeba host transcription by AnkH maybe different from human macrophages.

Our data indicate LARP7-AnkH interaction impedes 7SKsnRNP complex
formation leading to transcriptional elongation of certain genes by Pol II resulting in host
global transcriptional reprogramming. Translocation of AnkH into the host cell results in
up regulation of pathways regulating transcription and immune responses in the host cell.
However, in the absence of AnkH there is an upregulation in pathways involved in
vesicular trafficking, autophagy and apoptosis. Due to the up regulation in immune
response pathways, a series of cytokine levels were measured in response to infection.
Ten cytokines levels were measured but only 8 were at at detectable levels. The multiplex
data showed that of the cytokines tested, IL-1α was the only one that had levels that were
significantly higher in cells infected with the ∆ankH compared to the cells infected with
the WT strain. IL-1α was one of the cytokines identified as differentially regulated in the
absence of AnkH and these multiplex data support those findings. These observations
support our finding for the role of AnkH-LARP7 interaction in modulating function of
the 7SK snRNP complex in human macrophages but the effect of AnkH on host global
transcription is likely impacted by interaction of AnkH with other host targets.

Although AnkH had previously been studied, little was known about the crystal
structure. The crystal structure revealed that AnkH contains four ARDs, two of which
contain an asparagine hydroxylation motif located on the outer surface of the ARD
domain. The crystal structure also revealed a cysteine-like protease pocket which had
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previously not been detected based on secondary structure predictions. The ARDs are
involved in protein-protein interactions by acting as a scaffold for proteins to bind. ARDcontaining proteins can typically bind to one or more targets [54, 181]. The ARD
domains contain multiple ankyrin repeats that form crescent-like structures and contact
their binding partners on the concave side that is formed from the inner short helices and
the long β-hairpin/loop regions connecting the ankyrin repeats [182]. Several residues on
the putative target binding side of AnkH ARD that are located on the tips of the interrepeat loops are required for the function of AnkH in intracellular replication of L.
pneumophila. These sidechains are exposed to the solvent and aside from Tyr31 and
Asn97, are not in contact with the cysteine protease-like domain. Therefore, mutation of
these residues likely disrupts the ability of AnkH to interact with LARP7 or other specific
host targets. Data has shown that residues within the β hairpin loops of the ARDs are
involved in binding to substrates. Our data are consistent with these findings as we have
shown that substitution in β hairpin loops of the ARD3, particularly at residue 97, results
in reduced binding of AnkH to LARP7, indicating that this loop likely is the loop that is
interacting with the LARP7 component of the 7SK snRNP complex. Not only do these
mutations affect binding of AnkH and LARP7, but the residues within the ARDs also
resulted in a defect in intracellular replication within human macrophages similar to the
∆ankH indicating that each repeat is required for the function of AnkH.
We have previously shown that AnkH is hydroxylated at N59 [179]. We have also
shown that the host FIH asparagine hydroxylase localizes to the LCV and is involved in
hydroxylating another L. pneumophila effector, AnkB [179]. Asparagine hydroxylation
of AnkB is also required for the function of the AnkB effector in intracellular replication
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of L. pneumophila [179]. The asparagine hydroxylation motif is commonly found in
ARDs and serve as target sequences for the FIH asparagine hydroxylase [262, 263],
which is responsible for hydroxylating an asparagine residue within this motif [179]. This
hydroxylation can act as a molecular switch for protein-protein interactions by either
inhibiting or strengthening the interaction [263-265]. The N59 and N92 residues of AnkH
are located at the beginning of the loop connecting two neighboring ARDs. Mutation of
either of these residues results in a significant decrease in intracellular replication of
L.pneumophila, indicating that the asparagine hydroxylation motifs are important for the
function of AnkH in the intracellular replication. A possible explanation for the role of
this modification is provided by the structure of the ankyrin domain of the mouse notch 1
with this modification (PDB ID: 2QC9) [266]. The FIH-hydroxylated asparagine is
located at a sharp bend of the backbone and hydrogen bonds through the added hydroxyl
with the aspartic acid sidechain two residues back and located at the other corner of the
bend. It has been suggested that this additional hydrogen bond might help to stabilize the
loop in the ARD [266]. Equivalent aspartic acids are found in AnkH at positions 57 and
90, two back from the asparagines. Therefore, a similar possibility of stabilization of the
inter-ARD loops has to be considered for AnkH as a means to strengthen the interaction
with its cellular target.
The crystal structure also revealed a cysteine-like protease domain. The function
of this domain is currently unknown. Our data show that the predicted protease catalytic
triad is essential for the function of AnkH, but we were not able to detect protease
activity in vitro for AnkH purified from E. coli (unpublished data) or cleavage of the
interacting partner LARP7. We speculate that the lack of a detectable protease activity in
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vitro is likely due to the closed nature of the catalytic pocket of purified AnkH,
suggesting a requirement of its binding to a substrate in vivo to potentially open the
pocket for catalysis. In most cases, homologs of AnkH contain all domains and in some
cases the C-terminal domain is partially or fully missing. All these homologs conserve
the His-Asp-Cys catalytic triad residues, which are embedded in conserved patterns:
rGHa, D/NRg and GNCSWANV that is preserved down to ~30% sequence identity with
AnkH Cysteine-like protease domain. This would indicate that the cysteine-like protease
domain is important for the function of AnkH since it is conserved in AnkH homologs.
In summary, AnkH is targeted to the nucleus where it interacts with LARP7 and
likely other host targets, leading to reprograming of host transcription to promote
intracellular bacterial growth. This is mediated, at least in part, by the effect of AnkHLARP7 interaction and abolishment of interaction of LARP7 with critical subunits of the
7SK snRNP complex essential for its negative transcriptional elongation, leading to host
global transcriptional reprogramming. The conservation of AnkH in intracellular
pathogens harboring the Dot/Icm T4SS and its involvement in a conserved pathway
supports AnkH-LARP7 interaction and its partial effect on reprogramming global host
transcription, which is likely impacted by interaction of AnkH with other host targets. It
is most likely the AnkH-dependent host transcriptional reprogramming to have unique
consequences in various protist hosts compared to human macrophages. The crystal
structure of AnkH shows it contains an ARD with four ankyrin repeats containing two
asparagine hydroxylation motifs, a cysteine protease-like domain and a C-terminal
domain of unknown function. Critical residues in the ARD and the cysteine protease-like
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domains identified from the structure are shown to be required for AnkH-LARP7
interaction and function of AnkH in intracellular replication.
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CHAPTER 4:
CONCLUSIONS AND FUTURE DIRECTIONS
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No human proteins had previously been identified as interacting partners for
AnkH. In addition, no pathogenic factor has ever been shown to interact with a host
transcriptional complex. We show that the human LARP7 protein is an interacting
partner of AnkH. LARP7 is a component of a transcription regulatory complex, the 7SK
snRNP. After identifying LARP7 as an AnkH interacting partner we wanted to determine
if other components of the 7SK snRNP complex were associated with AnkH. We were
not able to detect other components of the 7SK snRNP complex during
immunoprecipitation. Native protein levels were measured during immunoprecipitation
of AnkH, so these proteins may not occur in high abundance which would make them
harder to detect. One way we could further test if there were any interactions between the
complex and AnkH would be to over express the different complex components and
perform co-immunoprecipitation to determine if they are capable of interacting. It would
also be beneficial to show that the interaction of AnkH and LARP7 is occurring during
infection conditions and not just during ectopic expression of AnkH. An antibody
suitable for detecting AnkH via immunofluorescence does not currently exist so it would
need to be made in order to perform immunofluorescence during infection.
We show that AnkH has a subcellular localization to both the nucleus and the
cytoplasm of transfected cells. AnkH does not contain a known nuclear localization
signal (NLS) so the method by which it is being localized to the nucleus remains
unknown. Through better immunofluorescence, with both more tags and using an AnkH
specific antibody, it could more definitely be shown that AnkH localizes to the cell
nucleus. The localization could also be tested in the presence of LARP7 knock down to
determine if that alters the cellular localization of AnkH. There are multiple different
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classes of NLS. It is possible that AnkH harbors a modified signal sequence that aids in
transport to the nucleus of cells. There may also be an uncharacterized NLS located
within AnkH which is what is responsible for localization. AnkH may complex with a
host factor harboring an NLS, which would enable its nuclear localization.
Knockdown of LARP7 resulted in a significant defect in intracellular replication.
We hypothesize that this is a result of the shutdown of transcriptional regulation within
the host cell which creates an environment that negatively affects bacterial proliferation.
It is possible that during infection AnkH interacts with a portion of the pool of LARP7
present within the host cell. This would leave room for partial transcriptional regulation
through the 7SK snRNP complex. We hypothesize that a favorable environment for L.
pneumophila is achieved by creating a balance between functional and non-functional
7SK snRNP transcriptional regulation through the LARP7-AnkH interaction. This theory
could be tested using varying methods. One way to test this would be to determine the
stability of the 7SK snRNA during infection, since LARP7 is required for formation of
the complex and the 7SK snRNA is degraded when not part of the 7SK snRNP complex.
This could be achieved by using RT-PCR to measure the amount of 7SK snRNA present
during infection compared to uninfected cells or by using northern blots to test the
stability of the 7SK snRNA. RNA-FISH could also be used to visualize 7SK snRNP
location and concentration as well. To test if the 7SK snRNP complex is functioning, PTEFb is responsible for phosphorylating RNA pol 2 but when it is sequestered in the 7SK
snRNP complex it is not capable of performing its kinase activity. As a result, measuring
the phosphorylation of RNA pol 2 would be an indicator of P-TEFb function which could
show whether the 7SK snRNP complex is properly functioning. To test partial shutdown
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of transcription as a result of AnkH the total RNA from infected cells could be compared
to the total RNA from uninfected cells to quantitate transcription. Radiolabeled
nucleotides could also be used to determine transcription levels by measuring their
integration in mRNA. Another method could be to knockdown LARP7 and perform
RNASeq. The 7SK snRNP complex does not function in the absence of LARP7 and
comparing the transcriptome of RNAi treated cells to the transcriptome of infected cells
could aid in determining if infection with L. pneumophila is indeed causing a partial
shutdown in transcription.
The crystal structure of AnkH revealed that AnkH contains four ankyrin domains,
a cysteine-like protease domain, two asparagine hydroxylation motifs and a CAP domain.
Through point mutation of specific residues within the ANK domains, asparagine
hydroxylation motif and the cysteine-like protease domain, we determined that all are
important for the function of AnkH because mutation resulted in a decrease in
intracellular proliferation. We also show that the ANK domains are required for AnkHLARP7 interaction through co-immunoprecipitation of the point mutations and LARP7.
Asn97, in particular, is likely important due to the observation that less LARP7 was able
to be pulled down when this residue was mutated based on the amount of AnkH also
present. It is also possible that loops 1 and/or 2 play a role in the interaction of AnkH and
LARP7 as well. The effect the asparagine hydroxylation sites and the cysteine-like
protease domain on the interaction between LARP7 and AnkH is unknown. This could be
tested by performing co-immunoprecipitation of the AnkH Asn hydroxylation and
cysteine-like protease domain mutants with LARP7. The ARD mutants would also need
to be tested with other confirmed interacting partners to determine which loops are

98

responsible for the interaction between AnkH and its host targets. Another way the
substitution mutants could be tested for their effect on AnkH interactions would be to
utilize the yeast 2-hybrid system. The prey proteins have already been determined. The
substitution mutants would have to be created in the AnkH bait construct and then used
with the prey targets for yeast mating. If a mutation does alter AnkH binding to a target,
then we would see results indicative of no interaction using this system.
The function of AnkH during infection of different protozoa hosts has not been
elucidated. Further characterization of the host target and function of AnkH in amoeba
would determine whether the function of AnkH is host specific and whether the response
seen in human macrophages is an accidental response to an amoeba-adapted effector.
Amoeba contain a LARP7 homolog. Therefore, the LARP7-AnkH interaction may also
occur in amoeba but the affected cellular pathways in amoeba may be different from
human macrophages. One way to test this would be to perform RNASeq on infected
amoebae and compare the results to the human macrophage transcriptome results. This
would help identify which pathways are affected in each host and to determine where the
differences are. Similar pathways affected could be pursed further as they would likely be
more indicative of the true function of AnkH.
While we have some answers as to the function of AnkH, it is still unclear how
AnkH enables the survival and robust intracellular replication of L. pneumophila within
target host cells. In order to more fully answer this question, the genes identified by
RNASeq as being differentially regulated in the absence of AnkH and numerous
pathways were identified by this screen, each one gives more insight into the function of
AnkH and each would need to be further explored to determine how AnkH is altering
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these pathways. Determining what other proteins identified in the yeast 2-hybrid screen
will aid in answering this question since each will likely act on parts of different
pathways.
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